Jamie Bell
Nalu PNS system significantly reduces healthcare-related costs in chronic pain patients
Nalu Medical has announced the publication of a study in the journal Pain Management showing that the use of Nalu peripheral nerve stimulation (PNS) therapy...
Mainstay announces positive outcomes in “landmark” restorative neurostimulation trial
Mainstay Medical has announced the publication of positive one-year primary assessment results from the RESTORE randomised clinical trial evaluating ReActiv8 for the treatment of...
Abbott, Medtronic announce major CE-mark approvals for deep brain stimulation technologies
Abbott and Medtronic—two leading players in the neuromodulation space—have both announced significant CE-mark approvals relating to their respective deep brain stimulation (DBS) technologies.
Abbott announced...
Cerevasc announces first enrolment in STRIDE trial evaluating eShunt system for...
Cerevasc has announced the first enrolment of a patient in the STRIDE clinical trial evaluating the company’s eShunt system in patients with normal-pressure hydrocephalus...
BRAIN.Q achieves CE mark of “breakthrough therapy” for reducing disability following...
BRAIN.Q has announced that the CE mark has been granted for its BQ 2.0 system, which is designed to reduce disability following ischaemic stroke.
A...
Q’Apel announces CE-mark approval for Armadillo SelectFlex neurovascular access system
Q'Apel Medical has announced that it has received CE-mark certification for its Armadillo SelectFlex neurovascular access system. As noted in a company press release, this “first-of-its-kind”...
Medtronic expands US carotid market presence with exclusive Contego distribution agreement
Medtronic announced today that it has entered into an exclusive US distribution agreement with Contego Medical. Under the agreement, Medtronic will be the sole...
Reversible thrombolytic could alleviate US “tribalism” around tPA and help redefine...
Following Basking Biosciences’ recent announcement that the first acute ischaemic stroke patients have received its novel thrombolytic therapy as part of the Phase 2...
Kaneka announces acquisition of Endostream Medical
Kaneka Corporation has announced that—on 23 December 2024—it acquired 96.8% of shares in Israeli medical equipment company Endostream Medical.
By combining its own manufacturing and...
Carotid stenting performed by trained neurointerventionists linked to lower complication rates...
A retrospective study has indicated that carotid artery stenting (CAS)—when performed by fellowship‐trained neurointerventional physicians in comprehensive stroke centre (CSC) settings—was associated with a...
Anaconda Biomed appoints Trent Reutiman as new CEO
Anaconda Biomed has announced that it has named long-time medtech executive Trent Reutiman as its new chief executive officer (CEO).
A press release details that, based...
AHA statement: Palliative care can help to optimise post-stroke quality of...
Palliative care—an approach that helps people manage pain and other symptoms during all stages of a serious illness, rather than simply being an ‘end-of-life’...
Stroke detection innovator Wellumio expands into US market
Wellumio is expanding its global footprint by launching a new subsidiary in California, USA—a strategic move that, according to the company, lays the groundwork for...
North American Neuromodulation Society announces 2025 award recipients ahead of annual...
The North American Neuromodulation Society (NANS) has announced its 2025 award winners ahead of the NANS annual meeting (30 January–1 February, Orlando, USA), recognising...
NeuroNews’ top 10 most popular stories of December 2024
NeuroNews’ final top 10 of 2024 features a number of the biggest talking points and new data presentations from two major neurovascular events: the...
First patients enrolled in neurovascular study of Navigantis’ robotic platform
Navigantis has announced the first successful neurovascular clinical cases performed with its Vasco interventional robotic platform for patients suffering from neurovascular disorders.
"This achievement marks...
TargED doses first participant in Phase 1 clinical trial of “groundbreaking”...
TargED Biopharmaceuticals has today announced that it has commenced clinical development with the dosing of the first participant with TGD001—a “groundbreaking” thrombolytic designed to...
Viz.ai announces integration of Avicenna.AI’s CINA-ASPECTS stroke severity assessment tool
Leading artificial intelligence (AI)-based medical imaging companies Viz.ai and Avicenna.AI have announced the integration of Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into Viz.ai’s One platform....
Further research on balloon guide catheters required following inconclusive PROTECT-MT results
Recently presented results from the PROTECT-MT randomised controlled trial (RCT) have indicated worse functional outcomes following stroke thrombectomy with a balloon guide catheter (BGC)...
Latest ‘super-bore’ catheter technology shows promise in initial clinical experience
A device described as the latest addition to a growing group of ‘super-large bore’ catheter technologies has demonstrated “extremely positive” outcomes in early clinical...
Fluid Biomed raises US$27 million to advance ‘world-first’ bioabsorbable stent in...
Fluid Biomed has today announced the close of an oversubscribed US$27 million Series A equity financing co-led by Amplitude Ventures and an undisclosed major...
BRAIN 2024: ICAD confronted as globally relevant yet under-addressed stroke aetiology
While intracranial atherosclerotic disease (ICAD) is often cited in the context of its greater prevalence among patients in China and other parts of Asia,...
Endovascular treatment of brain aneurysms—is under 5mm a ‘go’ or ‘no-go’...
In light of recently presented and generally positive findings from the COAST study, which deemed coiling to be safe in the treatment of small...
Philips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular...
Royal Philips has today announced the expansion of its strategic partnership with Sim&Cure—a partnership that started five years ago and is now entering into its...
Von Vascular presents early data on Algo smart pump at BRAIN...
Von Vascular has announced the first international presentation of data on its Algo smart pump at the 2024 BRAIN conference (2–4 December, London, UK). The...
RapidPulse receives US FDA approval for IDE study of innovative cyclic...
RapidPulse announced today that the US Food and Drug Administration (FDA) has agreed that the company can begin enrolment in an investigational device exemption...
Female sex, disease severity and vasospasm among predictors of post-SAH delayed...
A meta-analysis of more than 4,500 patients, presented recently at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates), has revealed...
Alveron Pharma closes €5 million seed extension financing to accelerate breakthrough...
Alveron Pharma has announced the closing of a €5 million series seed extension financing—worth approximately US$5.28 million—to advance the development of its innovative drug, OKL-1111,...
NeuroNews’ top 10 most popular stories of November 2024
NeuroNews’ November top 10 features a number of stories reporting new data and discussions around stroke thrombectomy—not only relating to its clinical effects, but...
Novel EVD catheter scoops US$100,000 SVINnovation prize
A novel catheter intended to improve on the tools currently available in neurosurgical external ventricular drain (EVD) placement was awarded a US$100,000 grand prize...
SELECT LATE trial gets US$7 million funding boost to evaluate stroke...
University Hospitals (UH) Cleveland Medical Center in Cleveland, USA has been awarded US$7 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI)...
“The race is on”: enthusiasm over neuroprotection endures despite historic failures
“The race is on—don’t miss the bus!”, were the words of David Liebeskind (University of California Los Angeles Health, Los Angeles, USA) as he...
RapidAI showcases Rapid Enterprise platform including Navigator Pro at RSNA 2024
RapidAI today announced the launch of its Rapid Enterprise platform—powered by Rapid Edge Cloud—which includes the addition of the Rapid Navigator Pro and third-party...
Rescue stenting linked to improved functional independence versus thrombectomy alone in...
In patients with large vessel occlusion (LVO) stroke caused by intracranial atherosclerotic stenosis (ICAS), rescue stenting following mechanical thrombectomy appears to lead to higher...
SVIN introduces Mechanical Thrombectomy Access Score via “groundbreaking” research paper
The Society of Vascular and Interventional Neurology (SVIN) recently announced the publication of a “significant” research paper in the journal Stroke, presenting the Mechanical Thrombectomy Access...
Revisiting unruptured aneurysm risk and the UK ROAR study
A lack of overall understanding regarding rupture risks is one of the most notable challenges impeding the successful treatment and management of brain aneurysms—and...
New studies support use of Viz.ai’s solutions for detecting suspected cerebral...
Viz.ai has announced new data supporting advancements in neurology and vascular care, with two studies—both set to be presented at the Radiological Society of...
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH...
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by...
EMVision announces positive clinical trial results with ‘world-first’ neurodiagnostic technology in...
EMVision has announced “exceptional results” with what the company claims is a world-first neurodiagnostic technology for identifying stroke and stroke types.
These results come from...
Landmark MMA embolisation trials published in New England Journal of Medicine
Detailed results from three randomised controlled trials (RCTs) evaluating middle meningeal artery (MMA) embolisation in the treatment of chronic subdural haematoma (cSDH) have been...
NVQI Quality Outcomes Database celebrates 25,000-procedure milestone
The Society of NeuroInterventional Surgery’s (SNIS) Patient Safety Organization (PSO)—in partnership with the NeuroPoint Alliance (NPA)—has announced that the NeuroVascular Quality Initiative Quality Outcomes...
Route 92 gains EU and MDSAP certification for its neurovascular product...
Route 92 Medical announced today that it has obtained CE-mark approval under the EU Medical Device Regulation (MDR) 2017/745 for its innovative line of...
Endostream announces European MDR certification of Nautilus intrasaccular system
Endostream Medical has announced that it has officially received European Union (EU) Medical Device Regulation (MDR) certification for its Nautilus intrasaccular system—a novel device...
Ox-01 neuroprotective candidate selected for evaluation in new US NINDS programme
FreeOx Biotech has announced that its uric acid-based leading compound, Ox-01, has been officially selected by the US National Institute of Neurological Disorders and...
Late-breaking data, SLICE collaboration and US$100,000 innovation prize on agenda for...
“This meeting is more than just a conference—it’s a community. And it’s dedicated to pushing the boundaries of what’s possible in the neurovascular space,”...
High blood pressure, atrial fibrillation and smoking among risk factors for...
People with conditions or habits like high blood pressure, atrial fibrillation and smoking not only have a higher risk of stroke, but may also...
NeuroNews’ top 10 most popular stories of October 2024
Last month saw the passing of esteemed surgeon and neuroendovascular pioneer Nick Hopkins. Given the seismic impact he had on the neurointerventional landscape and...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
Vivolta partners with Neurochase to manufacture electrospun microcatheters for delivery of...
Vivolta has announced the signing of a long-term partnership with Neurochase to manufacture electrospun microcatheters for delivering advanced central nervous system (CNS) therapies to...
Zap Surgical secures US$78 million in Series E funding led by...
Zap Surgical Systems has announced the successful closing of a US$78 million Series E funding round led by Qingdao Baheal Medical, with participation from...
Branch atheromatous disease-related stroke may warrant consideration as separate disease entity
Branch atheromatous disease (BAD)-related stroke—a “meaningful” yet “understudied” subtype of ischaemic stroke—could be categorised as a separate disease entity, according to the findings of...
Thanh N Nguyen
As one of six women currently leading major neurointerventional societies across the globe, Thanh N Nguyen (Boston, USA) is proudly playing a key role...
Physician feedback makes CEREGLIDE 71 a new gold-standard contender among stroke...
This advertorial, intended for readers outside the USA only, is sponsored by Johnson & Johnson MedTech Neurovascular.
“If you take all the good things about...
First prospective Indian thrombectomy registry shows high revascularisation rates and confirms...
Data from a registry claimed to be the first prospective registry on mechanical thrombectomy for stroke in India have revealed a number of key...
Hyperfine announces European launch with recent CE-mark approval
Hyperfine has announced the CE-mark approval of its latest generation of artificial intelligence (AI)-powered Swoop system software under the European Medical Device Regulation (MDR).
This...
Hereditary Brain Aneurysm Support achieves registered charity status
Hereditary Brain Aneurysm (HBA) Support—a patient-centred organisation providing support and resources for those affected by hereditary brain aneurysms—has announced its new status as a...
Stroke thrombectomy: Limitless potential or a success story nearing its final...
Mechanical thrombectomy has gone from strength to strength in the treatment of acute ischaemic stroke over the past decade—progressing beyond early-window large vessel occlusions...
“Transformative” new data advocate early blood-thinning therapy in patients with atrial...
People with atrial fibrillation (AF) who have a stroke could benefit from receiving blood-thinning treatments—known as direct oral anticoagulants (DOACs)—at an earlier stage than...
Zeta Surgical’s AI-powered navigation system gains US FDA 510(k) clearance expansion
Zeta Surgical has announced that its artificial intelligence (AI)-powered Zeta navigation system has received 510(k) clearance from the US Food and Drug Administration (FDA)...
Stroke researchers Lauren Sansing and Virginia Howard among AHA’s 2024 award...
Two prominent figures in the field of stroke research—Lauren Sansing (Yale School of Medicine, New Haven, USA) and Virginia Howard (University of Alabama at...
Q’Apel Medical appoints Jay Hallinan as chief commercial officer
Q'Apel Medical has announced the appointment of seasoned medical device executive Jay Hallinan as its new chief commercial officer. In this role, Hallinan will lead the company's...
NeuroOne expands agreement with Zimmer Biomet for commercialisation of OneRF ablation...
NeuroOne Medical Technologies has announced the execution of an amendment to its existing distribution agreement with Zimmer Biomet—an update that will provide Zimmer Biomet...
NeuroNews issue 56 – US
Highlights:
New research finds that each hour saved between acute ischaemic stroke symptom onset and initiating a mechanical thrombectomy procedure is associated with a...
NeuroNews issue 56 – OUS
Highlights:
New research finds that each hour saved between acute ischaemic stroke symptom onset and initiating a mechanical thrombectomy procedure is associated with a...
Patient empathy and avoiding the trap of depersonalisation
In a guest piece for NeuroNews, Blaise Baxter (San Francisco, USA) discusses empathy and compassion in the working life of a neurointerventionist, and highlights...
TASTE-2 results suggest ‘significant reduction’ in stroke-related disability with Sanbexin
Simcere Pharmaceutical Group has announced that a new study with major clinical findings regarding Sanbexin—an edaravone-dexborneol concentrated solution for injection—was recently presented at the...
Every hour saved between stroke onset and thrombectomy could equate to...
A systematic review and meta-analysis of five studies and more than 11,000 patient records has indicated that each hour saved between acute ischaemic stroke...
Prolong Pharmaceuticals gains US FDA fast-track designation for novel stroke therapy
Prolong Pharmaceuticals has announced that its investigational therapy—PEGylated carboxyhemoglobin, bovine (PP-007)—has received a fast-track designation from the US Food and Drug Administration (FDA) for...
New research indicates sustained improvement in US stroke care over 20-year...
New research, published this month in the journal Stroke, has demonstrated the key role quality improvement programmes play in ensuring hospitals can adequately tackle the...
World Stroke Day 2024: UN General Assembly event emphasises need to...
Today, on World Stroke Day (29 October), here is a timely reminder that stroke is the second leading cause of death globally. Despite the...
World Stroke Day 2024: Terumo Neuro and Tulane University advocate stroke...
On World Stroke Day (29 October), Terumo Neuro has announced that it has partnered with Tulane University School of Medicine (New Orleans, USA) and...
World Stroke Day 2024: WSO launches global coalition to drive policy...
Today, on World Stroke Day (29 October), the World Stroke Organization (WSO) has announced the launch of a global coalition aimed at accelerating policy...
Philips and Medtronic partner to help accelerate access to life-saving stroke...
Royal Philips and Medtronic Neurovascular today announced a strategic advocacy partnership that will see the two companies attempt to raise awareness around potential health...
Ten years of MR CLEAN: Stroke thrombectomy’s evolution and ongoing challenges
This year, 25 October marks a full decade since the initial presentation of results from the MR CLEAN randomised controlled trial (RCT), which—along with...
Remedy announces US FDA orphan drug designation to treat large-territory acute...
Remedy Pharmaceuticals has announced that the US Food and Drug Administration (FDA) Office of Orphan Products Division (OOPD) has granted orphan drug designation to...
HEAL coating holds potential to “alleviate some of the biggest concerns”...
This advertorial is sponsored by Acandis.
While intracranial stents are among the devices most commonly used by neurointerventionists, one challenge that hampers their utilisation in...
Penumbra announces completion of enrolment in THUNDER IDE study
Penumbra has announced the completion of enrolment in its THUNDER investigational device exemption (IDE) clinical study for patients with acute ischaemic stroke.
THUNDER is evaluating...
ESMINT and ESNR sign memorandum of understanding to formalise collaboration
The European Society of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR) have today announced the signing of a memorandum...
Borvo Medical gains US FDA 510(k) clearance for novel, minimally invasive...
Borvo Medical has announced US Food and Drug Administration (FDA) 510(k) clearance of the Borvo Endoport Vacuum-Assisted Collection (EVAC) system—an advanced alternative to traditional...
InspireMD receives IDE approval from US FDA for CGUARDIANS II pivotal...
InspireMD has announced US Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II pivotal...
Nick Hopkins, 1943–2024: neurointerventional community mourns pioneer and “force of nature”...
Leo Nelson (Nick) Hopkins, a world-renowned surgeon, researcher and innovator who played a pioneering role in modern neurosurgery’s shift from open- to endovascular-first techniques,...
NeuroNews’ top 10 most popular stories of September 2024
Significant updates from key industry players including Microvention (now Terumo Neuro), Stryker and Johnson & Johnson MedTech Neurovascular dominate the list of NeuroNews’ most...
Carotid endarterectomy ‘remains useful and relevant’ in era of improving medical...
Findings from a retrospective analysis presented at the recent European Society for Vascular Surgery (ESVS) annual meeting (24–27 September, Kraków, Poland) provide evidence that—for...
Neurointerventionists ‘can rarely recover payment’ for out-of-network thrombectomy under US No...
A new study has found that neurointerventionists have “essentially no financially viable access to payment recovery” through the US No Surprises Act (NSA) for...
Carotid intervention linked to improved survival versus medical management in symptomatic...
New study data suggest that the interventional treatment of symptomatic carotid artery disease may result in an improved rate of age-adjusted overall survival compared...
Siemens Healthineers to co-lead EU UMBRELLA project aimed at improving stroke management
Siemens Healthineers has announced today that it will be joining forces with more than 20 industry and public partners—including seven leading stroke hospitals—to improve...
Synchron’s endovascular BCI achieves positive results in US COMMAND study
Synchron has announced positive results from the COMMAND study evaluating the safety and efficacy of the company’s Stentrode brain-computer interface (BCI) device in six...
New Viz.ai data indicate fewer futile transfers and substantial cost savings...
Viz.ai has announced clinical data validating the impact of Viz LVO in the management and outcomes of patients with large vessel occlusion (LVO) ischaemic...
London-based hospital becomes first in Europe to use Emboguard balloon guide...
The Royal London Hospital (London, UK) has become the first in Europe to use an innovative balloon guide catheter (BGC) called Emboguard (Johnson &...
Inbrain Neuroelectronics announces “world’s first” human graphene-based BCI procedure
Inbrain Neuroelectronics has announced the “world’s first” human procedure involving its cortical brain-computer interface (BCI) in a patient undergoing brain tumour resection. According to...
Roughly half of all healthy life lost to stroke is caused...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly...
Boston Scientific closes acquisition of Silk Road Medical
Boston Scientific has announced the close of its acquisition of Silk Road Medical—a medical device company that has pioneered a new approach for stroke prevention and...
Nevro announces launch of “only AI-driven technology in spinal cord stimulation”
Nevro Corporation has announced the US Food and Drug Administration (FDA) approval and limited market release of HFX iQ with HFX AdaptivAI—a responsive, personalised...
Toro Neurovascular announces first patient treatment in clinical trial of SuperBore...
Toro Neurovascular has announced the successful treatment of the first patient using its Toro 88 SuperBore aspiration catheter as part of a first-in-man clinical...
Hyperfine announces promising interim findings on portable, ultra-low-field MRI for acute...
Hyperfine has announced the presentation of interim data supporting the role portable, ultra-low-field magnetic resonance imaging (MRI) can play in acute stroke workup in...
Route 92 announces US$50 million Series F extension equity financing
Route 92 Medical has announced a new US$50 million extension to its previously announced, oversubscribed Series F financing, bringing the total raised to US$82...
Cerenovus and Biosense Webster among brands newly incorporated into Johnson &...
Johnson & Johnson (J&J) recently shared that its medical technology businesses—including Cerenovus and Biosense Webster, as well as Abiomed, DePuy Synthes, and Ethicon—will now...
Flow diverters “particularly effective” but also associated with “non-negligible” complication rate...
An analysis presented at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) has indicated that flow diverters...
Stryker completes acquisition of Nico Corporation
Stryker has announced that it has completed the acquisition of Nico Corporation—a company attempting to provide a systematic approach to minimally invasive surgery for...
Axonics prevails in patent infringement lawsuit with Medtronic
Axonics has announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against the company in US...
Sim&Cure and Siemens Healthineers partner to advance brain aneurysm treatment
Sim&Cure and Siemens Healthineers have announced a strategic partnership aimed at enhancing patient care and advancing brain aneurysm treatment.
A recent press release from the...
Latest TOBAS analysis finds low neurological event rate among conservatively managed...
Patients with unruptured brain arteriovenous malformations (AVMs) who are allocated to conservative management, or ‘observation’, experience a low rate of neurological events, according to...
Anne-Christine Januel named new ESMINT president
Interventional neuroradiologist Anne-Christine Januel (Toulouse University Hospital, Toulouse, France) has been elected as the new president of the European Society of Minimally Invasive Neurological Therapy...
Microvention officially rebrands to Terumo Neuro, reflecting “expanded focus and strategic...
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced its official rebranding to Terumo Neuro, effective immediately.
This name change signifies a new...
Oxford Heartbeat completes patient recruitment in trial evaluating PreSize Neurovascular software
Oxford Heartbeat has today announced that the clinical impact trial of its artificial intelligence (AI)-powered PreSize Neurovascular software has successfully completed patient recruitment.
A company press release...
Tiny ‘magnetic robot armies’ could be used to treat aneurysmal brain...
Researchers have created nanoscale robots that could be used to manage bleeds in the brain caused by aneurysms, potentially enabling a more precise and...
NeuroNews’ top 10 most popular stories of August 2024
A number of highlights from the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) populate our list of most-read...
Philips and WSO publish policy paper calling for “revolution in stroke...
Royal Philips and the World Stroke Organization (WSO) have published a joint policy paper calling for a “revolution in stroke care” to make a real difference to the lives...
Remedy announces Phase 3 CHARM trial data indicating Cirara’s potential in...
Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a...
RapidAI and Alaska Stroke Coalition partner to overcome distance and other...
RapidAI and the Alaska Stroke Coalition (ASC) have announced their partnership on the ‘Rapid AK’ project—a three-year initiative focused on advancing health equity for...
ESC 2024: Mass AF screening via ECG plus heart failure biomarker...
Mass screening for atrial fibrillation (AF) using electrocardiography (ECG) together with a heart failure biomarker does not prevent ischaemic stroke or systemic in older...
HBA Support announces new patient-centred projects ahead of transition to registered...
Hereditary Brain Aneurysm (HBA) Support—a not-for-profit organisation providing information and support for individuals and families affected by hereditary brain aneurysms—has announced the upcoming launch...
Evasc announces treatment milestone alongside Eclips data presentation at ESMINT 2024
Evasc Neurovascular recently announced a “landmark achievement” during the 2024 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France), reporting...
Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...
Younger brain aneurysm patients at heightened risk of developing mental health...
Among brain aneurysm patients, the risk of developing a mental health condition has been found to be higher as compared to among peers without...
Frontiers in paediatric INR: addressing challenges and embracing opportunities
In a guest piece for NeuroNews, Carmen Parra-Fariñas (Toronto, Canada) discusses some of the key considerations that distinguish the growing, dedicated field of paediatric...
Clearmind Biomedical announces US FDA clearance and initial case with Neuroblade...
Clearmind Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for its Neuroblade system—a novel neuroendoscopy system that enables minimally invasive procedures...
EShunt system receives US FDA Breakthrough Device designation for hydrocephalus treatment
Cerevasc has announced it has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its eShunt system, which is intended...
COATING study results set to have “tremendous impact” on intracranial aneurysm...
This advertorial is sponsored by WallabyPhenox.
Ahead of the COATING study’s much-anticipated final analyses, principal investigator Laurent Pierot (Reims University Hospitals, Reims, France) sits down...
NeuroNews issue 55 – US
Highlights:
First-time COAST study results as well as several other highlights from the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
NeuroNews issue 55 – OUS
Highlights:
First-time COAST study results as well as several other highlights from the 2024 Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
First UK trial evaluating deep brain stimulation in children with epilepsy...
A UK clinical trial evaluating deep brain stimulation (DBS) in children with epilepsy recently got underway—and a teenager who was the patient to take...
Christophe Cognard
Throughout his life and career, Christophe Cognard (Toulouse, France) has always sought to help advance the interventional neuroradiology (INR) space, and make the management...
The debate: general anaesthesia or conscious sedation in stroke thrombectomy?
While the recently presented SEGA trial and many other studies have attempted to establish which of the two prevalent methods for medically inducing a...
Novel BCI technology allows ALS patient to communicate intended speech
A new brain-computer interface (BCI) developed at University of California (UC) Davis Health (Sacramento, USA) has allowed a man with severely impaired speech due...
Medtronic receives “landmark” US FDA approval for asleep deep brain stimulation...
Medtronic has received US Food and Drug Administration (FDA) approval of asleep deep brain stimulation (DBS) surgery for people with Parkinson’s disease and people...
Johanna T Fifi named president for Society of NeuroInterventional Surgery
Johanna T Fifi, an interventional neurologist at Mount Sinai Hospital (New York, USA), has been named the 2024–2025 president of the Society of NeuroInterventional...
Arissa Medical enrols third cohort of patients in first-in-human Syntra pilot...
Arissa Medical has announced the third enrolment of patients into its Syntra study—an early feasibility pilot study evaluating the safety and efficacy of the...
NeuroNews’ top 10 most popular stories of July 2024
Industry updates—including several revealed during this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA)—garnered much of our readers’ attention...
Magnus highlights new SAINT clinical data at 2024 NYC Neuromodulation Conference
Magnus Medical has announced promising new clinical data on its Stanford accelerated intelligent neuromodulation therapy (SAINT) at the 2024 NYC Neuromodulation Conference (31 July–4...
MMI completes “world-first” robotic preclinical study in neurosurgery with Symani system
Medical Microinstruments (MMI) recently announced the completion of a preclinical study that demonstrated the feasibility of the Symani surgical system in neurosurgical procedures. Adnan Siddiqui...
Synchron announces first use of Apple Vision Pro with brain-computer interface...
Synchron has announced the world’s first-ever use of Apple Vision Pro by one of the patients implanted with the Synchron brain-computer interface (BCI).
Mark, a...
Cost-flexible devices and boosting thrombectomy uptake in the developing world
The growth of intravenous thrombolysis (IVT) coupled with the advent—and ongoing expansion—of mechanical thrombectomy has seen acute stroke transform from “a diagnosable and hardly...
New research highlights novel ‘complete clot ingestion’ metric for aspiration thrombectomy
Potentially groundbreaking research was presented recently at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA), with Robert Starke (University...
Gravity launches Supernova stent retriever and Neutron aspiration catheter for global...
Gravity Medical Technology has announced the launch of its next-generation stroke treatment devices: the Neutron aspiration catheter and the Supernova stent retriever. Early adoption...
Late-breaking data shed new light on post-thrombectomy rescue stenting
Two data analyses presented at the recent Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) have revealed new insights on...
Silk Road celebrates milestone of 100,000 TCAR procedures
Silk Road Medical has announced the milestone of more than 100,000 transcarotid artery revascularisation (TCAR) procedures having been performed to date.
“A growing number of...
COAST is clear: study finds coiling safe in small brain aneurysms
Coil embolisation of smaller intracranial aneurysms—those less than 5mm in size—has been found to be a safe approach, as per data presented for the...
Navigantis secures US$12 million to advance development of Vasco robotic platform
Navigantis has announced the closing of a US$12 million Series A financing led by Puma Venture Capital, with participation from Cormorant Asset Management and Mirae Asset...
US Medicare “continues to undervalue” stroke thrombectomy, new research shows
Despite mechanical thrombectomy’s high success rate in saving the lives of stroke patients, Medicare is paying lower rates over time for the procedure in...
Brainomix announces presentation of US data validating AI technology in stroke...
Brainomix has announced new data from studies that were presented this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
Study determines proximity to coal mines among non-medical factors potentially leading...
Research presented earlier this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA) has highlighted the effect of...
Non-English-speaking stroke patients less likely to reach hospital via ambulance or...
Non-English-speaking patients are less likely to arrive by ambulance when experiencing stroke symptoms, and also less likely to receive a mechanical thrombectomy procedure, according...
Radical presents initial data on recently US FDA-cleared catheter technology at...
Radical Catheter Technologies has announced 510(k) clearance by the US Food and Drug Administration (FDA) for its Radical catheter—which, the company claims in a...
The modified Rankin scale as a stroke trial endpoint: important, but...
The modified Rankin scale (mRS) is something of a default clinical outcome metric in many contemporary stroke studies, but—as Eva Mistry and Paul Wechsler...
Spryte Medical receives Breakthrough Device designation from US FDA for neuro...
Spryte Medical has announced that its neuro optical coherence tomography (nOCT) technology has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA)....
Imperative announces clinical findings from pivotal trial evaluating Zoom reperfusion system
Imperative Care has announced that late-breaking data from the Imperative trial were presented recently at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting...
Data analyses reveal possible link between gastrointestinal syndromes and brain aneurysm...
There is a potential connection between a diagnosis of certain gastrointestinal (GI) syndromes, and the formation and rupture of intracranial aneurysms, according to research presented...
Novel liquid embolic agent meets primary feasibility and safety endpoints in...
Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the...
Microvention announces publication of one-year results from CLEVER study
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the recent publication in the Journal of NeuroInterventional Surgery (JNIS) of one-year results from...
Study indicates updated stroke evaluation protocols increase patient access to thrombectomy...
Changing standard procedures for evaluating and treating patients with suspected stroke has led to improved access to lifesaving stroke surgery across the US state...
Rapid Medical completes initial neurovascular cases in USA with Drivewire 24...
Rapid Medical has announced the first procedures in the USA with the breakthrough deflectable access platform Drivewire 24, doing so at the ongoing Society of...
Stroke risk linked to climate, financial and medical vulnerability in US...
Worsening air quality and temperature extremes are linked to increased stroke burden, according to a study presented at this year’s Society of NeuroInterventional Surgery...
Q’Apel Medical appoints Jodie Fam as new CEO
Q'Apel Medical has announced the appointment of Jodie Fam as its new chief executive officer (CEO). With more than two decades in the medical...
Route 92 Medical announces commercial launch of FreeClimb 88 catheter system
Route 92 Medical today announced the commercial launch of the FreeClimb 88 catheter system comprising the FreeClimb 88 catheter and the Tenzing 8 delivery...
Saluda announces presentation of two chronic pain biomarker-based analyses at ASPN...
Saluda Medical has announced the recent presentation of two abstracts analysing biomarker-based spinal cord stimulation (SCS) data at the 2024 American Society of Pain...
Anaconda Biomed receives IDE approval to initiate enrolment in ATHENA study
Anaconda Biomed has announced that it has received conditional investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin...
Cerevasc appoints two new medical device leaders to board of directors
Cerevasc has announced two new appointments to the company’s board of directors. Shlomi Nachman, former company group chairman of Cardiovascular and Specialty Solutions and...
Imperative announces US FDA clearance and initial cases with “first” stroke-specific...
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 6Fr insert catheters, the company’s latest innovation in elevating...
Boston announces clinical data from chronic pain portfolio at ASPN 2024
Boston Scientific Corporation has announced the presentation of positive five-year pooled results for the Intracept intraosseous nerve ablation system, measuring outcomes across three clinical...
Mainstay announces receipt of European and Australian approvals for ReActiv8 MRI...
Mainstay Medical has announced that it has received regulatory approvals in the European Union, the UK and Australia of full-body magnetic resonance imaging (MRI)...
Sensome signs exclusive commercial distribution agreement for clot-sensing guidewire in Japan
Sensome has announced an exclusive distribution agreement in Japan with Cosmotec, an M3 Group company, for its smart clot-sensing guidewire used in mechanical thrombectomy....
NeuroNews’ top 10 most popular stories of June 2024
A number of major players in the neurovascular device industry—including Medtronic, Microvention/Terumo and Penumbra—announced newly launched technologies throughout June. These updates, coupled with insights...
The Ottawa Hospital first to adopt Vena Medical’s BDAC device
The Ottawa Hospital (TOH) in Ottawa, Canada has successfully adopted Vena Medical's Balloon Distal Access Catheter (BDAC) into its stroke treatment protocol. This follows...
Microvention announces publication of SOFAST clinical data
Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced the publication of data from SOFAST—a prospective, multicentre US study assessing the efficacy...
Avicenna.AI secures European MDR certification for AI medical imaging portfolio
Avicenna.AI has received Medical Device Regulation (MDR) certification for five of its algorithms from British Standards Institution (BSI) Medical Devices—a development that means the...
Smoking cessation remains a “ripe target” for improved medication adherence in...
New data presented at the 2024 Vascular Annual Meeting (VAM; 19–22 June, Chicago, USA) have revealed poor overall rates of medical therapy adherence in...
Recent breakthroughs in cSDH intervention may lead to “HERMES-style collaborative”
Following their initial presentation earlier this year, two randomised controlled trials (RCTs) indicating positive outcomes with middle meningeal artery (MMA) embolisation in chronic subdural...
US researchers named first-ever ‘Sacco Scholars’ for work in brain health
The American Academy of Neurology (AAN) and American Heart Association (AHA) have awarded the first-ever Ralph L Sacco Scholarships for Brain Health to two...
Evasc completes successful first case with Eclips Short Landing Zone device...
Evasc Neurovascular has announced the successful use of the Eclips Short Landing Zone device in treating all anterior communicating artery (ACOM) and middle cerebral...
“Terrible complication” highlights subtle challenges of treating dAVFs via embolisation
“I think complication discussion is one of the most important parts of our job,” said Edoardo Boccardi (Niguarda Hospital, Milan, Italy), prefacing his presentation...
ESMINT formalises collaboration with French Society of Neuroradiology
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has signed a memorandum of understanding (MOU) with the French Society of Neuroradiology (SFNR) in...
Zeto announces winners of Clinical Trial Sponsorship programme
Zeto has revealed the winners of its 2024 Clinical Trial Sponsorship programme. This initiative, announced at the 2023 Society for Neuroscience Convention (11–15 November,...
Microvention announces US availability of LVIS EVO intraluminal support device
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the LVIS EVO intraluminal support device is now commercially available for the treatment...
NeuroOne announces first-in-human ablations completed with OneRF system
NeuroOne Medical Technologies Corporation has announced that the OneRF ablation system was recently used at a prestigious hospital located in Jacksonville, USA to successfully...
Researchers highlight potential for autonomous stroke thrombectomy treatments in new paper
The use of robots in the autonomous treatment of stroke patients could widen access to time-sensitive emergency mechanical thrombectomy procedures, as evidenced by a...
Boston Scientific obtains CE mark for image-guided programming software in DBS
Boston Scientific Corporation has obtained a CE mark for the Vercise neural navigator 5 software with STIMVIEW XT technology, which—when used as part of...
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes...
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable...
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and...
High stroke and death rates relating to carotid stenting in the Pacific Northwest of the USA may be driven by the selection of high-risk...
Penumbra announces European launch of BMX81 and BMX96 neuro access offerings
Penumbra has announced the CE mark and European launch of BMX81 and BMX96—devices designed for the neurovascular management of ischaemic and haemorrhagic stroke. A...
CEA versus TCAR: surgeons should be familiar with both procedures and...
When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularisation (TCAR) in the treatment of carotid artery stenosis, operators...
ESO taskforce provides forecast for European launch of stroke thrombolysis drugs
The European Stroke Organisation (ESO) Executive Committee’s Thrombolysis Taskforce has provided “important updates” regarding the security of supply for Metalyse (tenecteplase) and Actilyse (alteplase)...
Short-pulse DBS appears more effective than conventional DBS in tremor but...
In a systematic review and meta-analysis of the current literature, deep brain stimulation (DBS) with a short pulse width has been shown to potentially...
New Siemens-WSO partnership to tackle stroke’s “disastrous disease trajectory”
Siemens Healthineers and the World Stroke Organization (WSO) have announced a two-year partnership to develop the acute stroke workforce, and improve treatment and care...
Zeto obtains US FDA 510(k) clearance for next-generation brain monitoring product
Zeto has announced that its innovative, next-generation brain monitoring product, named the ONE, has received 510(k) clearance from the US Food and Drug Administration (FDA).
"Zeto...
NeuroNews’ top 10 most popular stories of May 2024
Global conference coverage piqued NeuroNews readers’ interest through the month of May—initially with discussions at the Charing Cross (CX) International Symposium (23–25 April, London,...
Adnan Siddiqui
While he is a neurosurgeon by trade, Adnan Siddiqui (Buffalo, USA) has delved into an increasing number of domains throughout his career—not only through...
Nalu PNS system achieves significant and durable pain reduction in COMFORT...
Nalu Medical has revealed findings from a landmark clinical trial evaluating its Nalu peripheral nerve stimulation (PNS) system, utilising the company’s proprietary micro-implantable pulse...
ESMINT signs memorandum of understanding with German Society of Neuroradiology
In acknowledgement of their shared goals and interests, the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the German Society of Neuroradiology (DGNR) announced...
First-in-human data demonstrate Clotild smart guidewire can safely automate clot characterisation
Earlier today, Sensome announced positive results from its first-in-human CLOT OUT clinical trial evaluating the safety and performance of the company’s Clotild smart guidewire...
Medtronic unveils next-generation Artisse intrasaccular device alongside new data at LINNC...
Medtronic has today announced the European launch of Artisse—a new intrasaccular device designed to treat intracranial aneurysms by conforming to the shape of the...
US researchers pioneer new brain imaging technique through ‘clear window’ in...
In what has been described as the first study of its kind, researchers from the Keck School of Medicine at the University of Southern...
Conformability, softness, simplicity and simulation enable Artisse to ‘personalise’ treatments in...
This advertorial, intended for readers outside the USA only, is sponsored by Medtronic.
In light of the official European launch of the Artisse aneurysm embolisation...
Positive HEMERA-1 data pave the way for further neuroprotection trials during...
Following the recent publication in Stroke: Vascular and Interventional Neurology of results from HEMERA-1, a prospective, multicentre trial evaluating the safety of novel neuroprotective...
Thrombolysis appears less effective in tandem-lesion stroke patients presenting directly to...
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure appears to be less effective in ischaemic stroke patients with carotid-artery tandem lesions, as compared...
Seven-year data provide “compelling evidence” that intracranial stenting does not confer...
Seven-year data from the Chinese CASSISS trial have, in the investigators’ view, provided “compelling evidence” that percutaneous transluminal angioplasty and stenting (PTAS) plus medical...
Mobile app successfully improves stroke medication adherence and risk-factor control
The use of a smartphone-based mobile application may be an effective method for improving medication adherence and risk-factor control among stroke survivors, and appears...
Varied tenecteplase data may provide clarity on the drug’s exact role...
This year’s European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland) saw a plethora of data on intravenous tenecteplase—from studies spanning Australia, Canada, China,...
Ceretrieve announces successful results in FIH study of stroke aspiration catheter
Ceretrieve has announced the successful results of the company's multicentre, single-arm study, showcasing the capabilities of its “state-of-the-art” aspiration catheter in stroke treatment.
The study—conducted across two...
Medtronic names Linnea Burman as new head of Neurovascular business
Medtronic has today announced that Linnea Burman will succeed Dan Volz as its senior vice president (SVP) and president of its Neurovascular business—part of...
Spryte publishes first-in-human study of novel intravascular brain imaging technology
Spryte Medical has announced the publication of a first-in-human study of its neuro optical coherence tomography (nOCT) technology in the peer-reviewed journal Science Translational Medicine, in...
Hippo-Cheetah combination: a whole new animal in aspiration thrombectomy
This advertorial, intended for US readers only, is sponsored by Q’Apel Medical.
Hot on the heels of the device’s Food and Drug Administration (FDA) clearance...
Stroke transfer protocols: what does the road ahead look like?
A number of somewhat conflicting studies have been published over the past year regarding triage and transport protocols for stroke. In light of the...
AiM partners with Brigham and Women’s Hospital to validate DBS lead...
AiM Medical Robotics has announced a collaboration with Brigham and Women's Hospital (BWH; Boston, USA), and the Surgical Navigation and Robotics (SNR) Lab at Harvard, to validate its cutting-edge robot...
ARISE I recommends multidisciplinary approach to managing brain aneurysms, chronic SDHs...
Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...
Vesalio appoints chief financial officer and announces new company headquarters
Vesalio is set to welcome J D McCulloch as its chief financial officer (CFO) for overseeing all financial aspects of the business, and helping...
XCath successfully performs first public telerobotic mechanical thrombectomy demonstration
XCath has announced the successful completion of a “first-of-its-kind” live telerobotic trial for stroke treatment, which took place between Abu Dhabi, United Arab Emirates...
Evidence weak but craniectomy may be superior to medical therapy in...
Despite the study very narrowly failing to meet its prespecified primary endpoint, the SWITCH randomised controlled trial has shown a substantial treatment effect with...
NeuroNews issue 54 – US
Highlights:
ARISE I recommendations on the management of intracranial aneurysms, chronic subdural haematomas (cSDHs) and brain arteriovenous malformations (AVMs)
First European presentation of PERFORMANCE...
NeuroNews issue 54 – OUS
Highlights:
ARISE I recommendations on the management of intracranial aneurysms, chronic subdural haematomas (cSDHs) and brain arteriovenous malformations (AVMs)
First European presentation of PERFORMANCE...
MagVenture and Magnus to collaborate on bringing SAINT neuromodulation system to...
MagVenture has announced a partnership with Magnus Medical that is intended to provide its industry-leading MagPro magnetic stimulation system to support an “exciting new chapter”...
Large-core ischaemic stroke patients with severe hypodensity may benefit less from...
While the randomised controlled SELECT2 trial initially found that patients with large-core ischaemic stroke receive a greater benefit from thrombectomy compared to medical management,...
‘Time is brain’ in ICH but early identification of stroke type...
The latest data from the INTERACT trials—a series of studies evaluating intensive blood-pressure (BP) lowering in acute haemorrhagic stroke—point towards the importance of initiating...
Thrombectomy shows long-term benefit in large-infarct stroke patients diagnosed via ‘pragmatic’...
The TENSION trial, conducted across 41 hospitals in Europe and Canada, has unveiled new insights into the long-term efficacy of endovascular mechanical thrombectomy in...
Brainomix announces increased thrombectomy rates at UK centres using its AI...
Brainomix has announced that results from what it claims is the largest prospective study of stroke artificial intelligence (AI) software were presented yesterday at...
‘TACTICS’ intervention shows promise for improving EVT access in Australia
TACTICS, a non-randomised intervention trial that aimed to optimise workflow and implement specialised imaging, has shown promise in improving access to endovascular therapy (EVT)...
Rapid Medical completes successful stroke procedures with “world’s first” robotic thrombectomy...
Rapid Medical has announced what it claims is the first successful robotic thrombectomy, in Medellín, Colombia. Two patients were treated with the robotic Tigertriever—an...
Higher income reduces stroke mortality risk by a third, new study...
New research, presented today at the 10th European Stroke Organisation Conference (ESOC 2024; 15–17 May, Basel, Switzerland), has revealed that high-income individuals have a...
Cerevasc secures US$70 million financing following US FDA approval of STRIDE...
Cerevasc announced recently that it has successfully completed the initial closing of a US$70 million Series B financing, which was jointly led by Bain Capital Life...
Hyperfine to expand into European markets with initial focus on France,...
Hyperfine has announced that it has entered into agreements with three experienced and accomplished distributors to support commercial expansion plans of the Swoop system—the...
Route 92 recalls catheter due to distal-tip separation at proximal marker...
Route 92 Medical is recalling specific lots of its products containing the Tenzing 7 delivery catheters due to multiple instances of distal-tip separation at...
Carryover effect exists and has “remarkably high” variability in spinal cord...
An international, multicentre study has confirmed the existence of the carryover or ‘echo’ effect—an interval before patients perceive the return of pain after their...
NeuroNews’ top 10 most popular stories of April 2024
NeuroNews’ top 10 most popular stories of April 2024 include the European launch of a new aspiration catheter for acute ischaemic stroke treatment, a...
RapidAI secures US FDA clearance for perfusion imaging tool within angio...
RapidAI has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its AngioFlow by RapidAI solution. As per a company press...
First European PERFORMANCE II release highlights durability of carotid stenting in...
The recent, first-time European presentation of the PERFORMANCE II trial’s findings—delivered by Ralf Langhoff (Sankt Gertrauden-Krankenhaus, Berlin, Germany) at the 2024 Charing Cross (CX)...
Penumbra launches Midway intermediate catheters and expands European stroke portfolio
Today, Penumbra announced the launch of its Midway 43 and Midway 62 delivery catheters, which are designed to provide ideal tracking and a stable...
New Myriad Spectra system described as “gamechanger” in high-grade glioma brain...
The latest product innovation by Nico Corporation, the Myriad Spectra system, has been described as a "game-changing advancement" by neurosurgeons with early experience using...
Scientia announces US FDA approvals for new line of microfabricated neurovascular...
Scientia Vascular has announced the US Food and Drug Administration (FDA) clearance of two uniquely engineered catheters: the Plato 17, a dimethyl sulfoxide (DMSO)-compatible...
Vagus nerve stimulation demonstrates promise as non-medical treatment for narcolepsy
An initial evaluation of vagus nerve stimulation (VNS) in narcolepsy patients has linked this neuromodulation modality to a “significant improvement” in daytime sleepiness, leading...
MindRhythm announces EPISODE-PS-COVID publication revealing Harmony’s reliability in identifying LVO stroke
MindRhythm has announced that results from the pilot phase of its three-phase clinical study, EPISODE, have been published in Academic Emergency Medicine. While pilot...
Study elucidates how patient age and electrode connectivity impact cognitive effects...
A study presented at the recent American Academy of Neurology (AAN) annual meeting (13–18 April, Denver, USA) has gone some way to elucidating how...
Route 92 announces US FDA 510(k) clearance for FreeClimb 54 reperfusion...
Route 92 Medical has today announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the FreeClimb 54 reperfusion system, comprised of...
ESMINT issues ‘call for experts’ to streamline EU medical device certification
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has issued a call for experts in neurointerventions to work with notified bodies over the...
Viz.ai and Nico announce collaboration to improve interventional ICH outcomes
Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered...
Insightec launches next-generation Exablate Prime neurosurgery platform in Europe
Insightec has announced the CE-mark approval and European launch of Exablate Prime, which the company describes as a “significant enhancement” to its Exablate Neuro...
Early technique switches “should be contemplated” following failed thrombectomy attempts
A retrospective analysis including data from close to 3,000 stroke patients has concluded that early changes in mechanical thrombectomy strategies may be associated with...
Cognito announces OVERTURE II results indicating durable effects of Spectris treatment...
Cognito Therapeutics has announced treatment results from OVERTURE II—an open-label extension (OLE) study of Spectris, the company’s potential disease-modifying therapy for the treatment of...
Growing haemorrhagic stroke burden in USA represents “major challenge” moving forward
The past three decades have seen a “notable rise” in the burden of haemorrhagic stroke across the USA and this, coupled with the increasing...
ENRICH trial results published in full in New England Journal of...
The entirety of the results from the ENRICH trial evaluating the early surgical removal of intracranial haemorrhage (ICH) have been published in the New England...
SpineX closes recruitment for trial evaluating Scone SCS technology in neurogenic...
SpineX has closed recruitment for the CONTINENCE clinical trial of its proprietary Scone device. The study began back in May 2022 and is evaluating...
Synchron launches patient registry for Stentrode brain-computer interface
Synchron has announced the launch of a community-centred brain-computer interface (BCI) registry to bring patients, carers and clinicians together to learn how BCI technology...
Study reinforces ‘widely held but underexplored’ view that ECT is safe...
Researchers have found that electroconvulsive therapy (ECT)—whereby an electric current is passed through the brain of a patient under general anaesthesia to induce a...
XCath highlights endovascular robotics innovation at SLICE Next Frontiers
XCath has announced that it presented at the recent Stroke Live Course (SLICE) Next Frontiers conference (3–4 April, virtual), hosted by Vincent Costalat (University Hospital...
NeuroNews’ top 10 most popular stories of March 2024
Major pieces of industry news from a number of innovators in the neurovascular space populate NeuroNews’ top 10 articles of last month—including NeuroOne, Artiria,...
RapidPulse’s precise cyclic aspiration technology “highly effective and safe” in LVO...
A study recently published online in the journal Interventional Neuroradiology has provided multicentre trial results that demonstrate the promise of using precise cyclic aspiration in the...
AI language model shows “encouraging” potential in locating brain lesions after...
Artificial intelligence (AI) may serve as a future tool for neurologists to help locate the part of the brain in which a stroke occurred,...
Silk Road adds Enroute NPS Plus device to TCAR portfolio
Silk Road Medical has announced the launch of its Enroute transcarotid neuroprotection system Plus (NPS Plus), which the company describes as a key component of...
Debates, case carousel and European first head up CX carotid and...
The programme for the 2024 Charing Cross (CX) symposium (23–25 April, London, UK) will see the topics of acute stroke care, carotid disease and...
Early DAPT, statin therapy and stent patency among predictors of good...
An analysis involving some 300 patients with anterior-circulation acute ischaemic strokes caused by tandem lesions has determined a number of factors that may be...
Dedicated devices support progress towards “next frontier” for stroke thrombectomy
This advertorial, intended for readers outside the USA only, is sponsored by Medtronic.
In light of a recent publication detailing the safe and effective use...
New data underscore physician experience levels required to derive benefit from...
Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on...
Research, training and industry all key to better thrombectomy care in...
This advertorial is sponsored by Medtronic.
Late last year, on 24 November, a decade’s work from a passionate group of physicians bore fruit, with the...
Viz.ai and Medtronic to collaborate on improving post-cryptogenic stroke care in...
Viz.ai has announced a strategic collaboration with Medtronic to improve the coordination of cryptogenic stroke patient care between neurology and cardiology teams.
For stroke patients...
Michihiro Tanaka
Michihiro Tanaka, director of Neurosurgery and Neuroendovascular Surgery at Kameda Medical Center (Chiba, Japan), speaks to NeuroNews to discuss the factors that have shaped...
Transradial achieves non-inferiority but procedural delays may mean femoral access remains...
In stroke patients undergoing a mechanical thrombectomy procedure, access via the radial artery may be non-inferior to access through the femoral artery in terms...
UK study indicates post-stroke depression may be more common and long-lasting...
Researchers have argued that “more needs to be done” for depressed stroke survivors in light of new findings showing that almost 60% of stroke...
NeuroOne initiates limited commercial launch of OneRF ablation system
NeuroOne Medical Technologies has announced that it has initiated a limited commercial launch of its OneRF ablation system, which has US Food and Drug Administration...
Avicenna.AI secures US FDA 510(k) clearance for two AI-powered imaging tools
Avicenna.AI announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-ASPECTS and CINA-iPE products.
CINA-ASPECTS is...
US patent office rejects Axonics’ latest challenge to Medtronic patents
Medtronic has announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office has affirmed the validity of claims...
Meta-analysis deems venous sinus stenting a safe and effective option in...
A meta-analysis published recently in the Journal of the Neurological Sciences has concluded that venous sinus stenting (VSS) appears to be a safe and...
NeuroNews issue 53 – US
Highlights:
The “major shift” likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH)
...
NeuroNews issue 53 – OUS
Highlights:
The "major shift" likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH)
...
Arissa reports initial six-month radiographic follow-up from Syntra FIH study
Arissa Medical has announced six-month digital subtraction angiography (DSA) follow-up of the first cohort of patients in its Syntra first-in-human (FIH) study—an early feasibility...
Mainstay announces publication of five-year follow-up data from ReActiv8-B trial
Mainstay Medical has announced the publication of the five-year follow-up from its ReActiv8-B randomised, sham-controlled, double-blinded trial in Neuromodulation: Technology at the Neural Interface.
There...
Shining a light on hereditary brain aneurysms
Intracranial aneurysms are a largely underestimated condition, for which global awareness and clinical research are currently lacking—and these sentiments apply even more pertinently when...
Axonics receives CE-mark approval for fourth-generation rechargeable SNM therapy
Axonics has announced that the Axonics R20 rechargeable sacral neuromodulation (SNM) system has received CE-mark approval.
Axonics expects to commence sales of the R20 to...
Single-centre analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-centre analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...
Nanoflex Robotics installs its first remote-ready robotics system in North America
Switzerland-based startup firm Nanoflex Robotics has announced that it recently installed its first remote-ready robotics system for neurovascular procedures at the Jacobs Institute (Buffalo,...
NeuroNews’ top 10 most popular stories of February 2024
Our list of the most popular stories from last month is dominated by first-time data releases from the International Stroke Conference (ISC; 7–9 February,...
Apollo Hospitals unveils South Asia’s first ZAP-X radiosurgery platform
Apollo Hospitals announced today that one of its centres in New Delhi, India has become the first hospital in South Asia to introduce the...
Nalu Medical closes US$85 million Series E financing round
Nalu Medical has announced the closing of an incremental US$20 million in equity financing from new investor B Capital, bringing its total Series E...
US study finds link between social factors and intravenous thrombolysis rate
For ischaemic stroke patients, social factors like education, neighbourhood and employment may be linked to whether they receive treatment with intravenous, clot-busting drugs, according...
Medtronic files complaint against Axonics to stop “unauthorised use” of neuromodulation...
Medtronic recently announced that it has filed a complaint with the US International Trade Commission (ITC), along with a parallel action in US District...
Silk Road expands TCAR portfolio with launch of tapered Enroute system
Silk Road Medical has announced the launch of its tapered Enroute transcarotid stent system to hospitals in the USA, expanding upon the company’s prior...
Artiria secures funding to support completion of stroke studies in Europe...
Artiria Medical has announced the successful closing of a Series A2 round worth US$6 million and the securing of a US$600,000 Fit Tech Growth...
ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy
This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...
Onward Medical awarded US FDA Breakthrough Device designation for ARC-BCI system
Onward Medical announced recently that it has been awarded Breakthrough Device designation (BDD) by the US Food and Drug Administration (FDA) for the ARC-BCI system, which...
No-reflow in clinical studies: Causes, rates and implications for patient outcomes
In a guest article for NeuroNews, Adnan Mujanovic (Bern, Switzerland) discusses a relatively unknown but potentially significant factor in stroke patients experiencing poor clinical...
One-year TESLA and SELECT2 data favour thrombectomy in large-core stroke patients
One-year follow-up data from two randomised controlled trials (RCTs) evaluating mechanical thrombectomy in patients with ischaemic strokes caused by large-core infarct volumes have demonstrated...
ASTER2 analysis links combined thrombectomy approach to improved reperfusion in proximal...
A subgroup analysis of the ASTER2 clinical trial has found that a first-line combined thrombectomy approach, which involves using contact aspiration and a stent...
Tivic completes enrolment in study of non-invasive, bioelectronic VNS therapy
Tivic Health Systems has announced that enrolment in its pilot clinical study of a proprietary approach to non-invasive vagus nerve stimulation (VNS) has been completed....
New trial tests electrical stimulation for treatment retention in opioid use...
The University of Cincinnati’s Center for Addiction Research and Spark Biomedical have jointly announced that they are conducting a clinical trial to help patients...
Route 92 completes enrolment in 250-patient SUMMIT MAX trial
Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its...
Brain stimulation plus rehabilitation produces improved upper-limb function in stroke survivors
Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands, and maintain these improvements for one year, within a...
Reteplase demonstrates superiority to alteplase in acute ischaemic stroke trial
Reteplase has demonstrated potential as an alternative to alteplase in patients requiring intravenous thrombolysis (IVT) to treat acute ischaemic stroke, as per the findings...
SNIS acknowledges “major shift” in chronic SDH treatment following new trial...
In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...
Addition of MMA embolisation reduces haematoma recurrence or progression in MAGIC-MT...
The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute...
Dual-stent retriever strategy demonstrates promise in TWIN2WIN clinical trial
Late-breaking findings from the TWIN2WIN trial—presented recently at the International Stroke Conference (ISC; 7–9 February, Phoenix, USA)—have demonstrated the potential benefits of performing mechanical...
Viz.ai gains US FDA 510(k) clearance for intracerebral haemorrhage imaging algorithm
Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended...
RapidAI highlights TIMELESS trial publication among other key ISC 2024 presentations
RapidAI has announced the publication of TIMELESS—a randomised trial evaluating the use of tenecteplase in acute ischaemic stroke treatment—in the New England Journal of Medicine...
Mainstay receives expanded MRI labelling from US FDA for ReActiv8 system
Mainstay Medical has announced that the US Food and Drug Administration (FDA) has approved full-body magnetic resonance imaging (MRI) conditional labelling for the ReActiv8...
STEM study finds improved outcomes with MMA embolisation over standard care...
Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...
ZODIAC trial reveals clinical benefits of zero-degree head positioning prior to...
Laying large vessel occlusion (LVO) ischaemic stroke patients flat with their heads at a zero-degree angle prior to a mechanical thrombectomy procedure has resulted...
Sensome initiates trial assessing tissue microsensor technology in peripheral artery disease
Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral artery disease (PAD). Clotild was...
Mivi Neuroscience presents primary endpoint results from EvaQ trial
Mivi Neuroscience has announced the primary endpoint results of its EvaQ trial—a prospective, multicentre, global, single-arm, US Food and Drug Administration (FDA)-regulated investigational device...
MMA embolisation plus surgery reduces risk of subdural haematoma recurrence in...
Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or...
Cerenovus launches next-generation Cereglide 71 catheter for ischaemic stroke revascularisation
Cerenovus, part of Johnson & Johnson MedTech, has announced the launch of its Cereglide 71 device—a next-generation intermediate catheter with TruCourse technology indicated for...
AI-based decision support system helps improve post-stroke vascular outcomes at three...
Ischaemic stroke survivors who received care recommendations from an artificial intelligence (AI)-based system experienced fewer recurrent strokes and heart attacks, and a lower rate...
Measuring plaque inflammation via SCAIL scores may improve carotid stenosis risk...
The use of a relatively novel scoring system, referred to as Symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL), has produced favourable predictive qualities versus the...
Halted MOST trial finds no benefit when adding blood thinners to...
Giving blood thinners in addition to clot-busting medications does not improve ischaemic stroke patients’ outcomes at 90 days, according to findings from the MOST trial, which...
New AHA statement seeks to improve recognition and management of cerebral...
A new scientific statement from the American Heart Association (AHA) emphasises the need to boost patient and physician awareness of cerebral venous thrombosis (CVT),...
Boston’s WaveWriter SCS systems gain expanded non-surgical back pain indication from...
Boston Scientific Corporation announced today that the US Food and Drug Administration (FDA) has approved an expanded indication of the company’s WaveWriter spinal cord...
New UK NICE guidance endorses AI-derived software in stroke assessments
A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two...
Carthera enrols first patient in trial assessing novel recurrent glioblastoma treatment
Carthera has announced the enrolment of the first patient in the SONOBIRD pivotal trial assessing its ultrasound-based Sonocloud medical device for the treatment of...
Advancing neurosurgery inside and outside the operating room
Brian Nahed (Boston, USA) outlines the latest advances in neurosurgery, and why it is important for those working in the field to keep up...
Lumosa, CHI Memorial announce new studies of stroke drug combining clot-busting...
Lumosa Therapeutics, in collaboration with CHI Memorial (Chattanooga, USA), has announced the initiation of multiple Phase 2 clinical trials for LT3001, which the company...
Synchron acquires equity stake in Acquandas
Endovascular brain-computer interface (BCI) technology firm Synchron has announced the acquisition of an equity stake in Acquandas—a leading technology provider specialising in state-of-the-art, high-precision components...
Ceroflo raises €6.4 million to aid progress of novel ICAD stroke...
Irish medical device firm Ceroflo announced today that it has raised €6.4 million in investment-round funding, which will be used to advance development of...
NeuroNews’ top 10 most popular stories of January 2024
A tribute to the late Conrad Yiu was NeuroNews’ most read story in January, indicating the impact he has had and will likely continue...
Basking Biosciences closes US$55 million financing to further reversible stroke thrombolytic
Basking Biosciences has announced the close of US$55 million in financing, which will be used to accelerate clinical development of its novel thrombolytic therapy...
Medtronic announces first neurointerventional case with CE-marked Rist 6Fr radial access...
Medtronic has announced the first neurointerventional case in Europe with its Rist 6Fr radial access catheter, which recently received regulatory approval for use in...
Low-dose ionising radiation may be “promising therapeutic strategy” in TBI and...
A research team led by City University of Hong Kong (CityU; Kowloon, Hong Kong) neuroscientists recently discovered that low-dose ionising radiation (LDIR), such as...
InspireMD receives CE-mark recertification under new EU regulatory framework
InspireMD announced today that it has received CE-mark recertification under the European Union’s (EU) new Medical Device Regulation (MDR) regulatory framework for its CGuard...
Abbott launches Liberta RC deep brain stimulation system with remote programming...
Abbott recently announced that it has received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC deep brain stimulation...
Researchers detail “more elegant” DBS approach for improving Parkinson’s symptoms
A team of physicians, neuroscientists and engineers at Duke University (Durham, USA) have reported multiple new strategies that use deep brain stimulation (DBS) to...
Stroke experts divided over concluding messages from SEGA trial results
The closing weeks of 2023 saw fresh findings comparing general anaesthesia (GA) to sedation in stroke thrombectomy disclosed for the first time, with leading...
Thanh N Nguyen becomes first woman to serve as SVIN president
Thanh N Nguyen, professor of neurology, radiology and neurosurgery at the Boston University Chobanian and Avedisian School of Medicine in Boston, USA, has been...
Leica Microsystems launches evolved version of ARveo 8 digital neurosurgery microscope
Leica Microsystems has launched an evolved version of its ARveo 8 digital visualisation microscope for neurosurgery. The ever-growing ecosystem, ARveo 8, enhances surgical visualisation...
Canadian hospital uses “world’s smallest camera” to see inside stroke patient’s...
Physicians at The Ottawa Hospital (TOH) in Ottawa, Canada recently became the first in the world to use a new stroke technology, the MicroAngioscope...
Nalu Medical presents long-term, holistic outcomes with PNS system at NANS...
Nalu Medical presented interim data from the “landmark” COMFORT randomised controlled trial (RCT)—indicating long-term and holistic pain management outcomes with its peripheral nerve stimulation...
Medtronic announces trial data on closed-loop and DTM SCS therapies at...
At this year’s North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA), Medtronic announced new data from two clinical trials demonstrating...
Cerevasc highlights eShunt study presentations from ABC WIN Seminar
Cerevasc has announced that data from clinical studies in the USA and Argentina examining the use of its eShunt system to treat communicating hydrocephalus were presented at...
Female hormone intake and its influence on cerebral cavernous malformations
As per an observational study published in the journal Neurology last year, female hormone therapy use may be associated with a higher risk of...
Midterm CARAS study results show cerebral ischaemic event incidence “should not...
The final publication of midterm results from the observational CARAS study suggest that cerebral ischaemic event (CIE) incidence in asymptomatic carotid stenosis patients “should...
Boston Scientific announces positive WaveWriter SCS findings from SOLIS trial
Boston Scientific Corporation has announced positive one-year results from the SOLIS randomised controlled trial, demonstrating sustained pain relief using its WaveWriter Alpha spinal cord...
Abbott gains expanded MRI labelling from US FDA for Proclaim DRG...
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its dorsal root ganglion...
Arissa Medical enrols first patients in first-in-human Syntra study
Arissa Medical has announced the enrolment of the first patients in its Syntra study—a first-in-human (FIH), early feasibility study evaluating the safety and efficacy...
Latest Pipeline Vantage device produces “acceptable outcomes” in unruptured aneurysms
A new study, published in the Journal of NeuroInterventional Surgery (JNIS) late last year, has assessed the safety of the latest iteration of the...
Medtronic gains US FDA approval for Percept RC deep brain stimulation...
Medtronic has announced the US Food and Drug Administration (FDA) approval of its Percept RC deep brain stimulation (DBS) system.
The rechargeable neurostimulator is the...
Nevro to highlight 25 scientific abstracts on spinal cord stimulation at...
Nevro Corporation has announced a series of data presentations supporting the use of the company's high-frequency (HFX) 10kHz spinal cord stimulation (SCS) therapy for...
Saluda announces plans to present new EVOKE study data at NANS...
Saluda Medical has announced that its data will be presented at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas,...
SPR Therapeutics announces multiple first-time data presentations set for NANS 2024
SPR Therapeutics has announced that it is set to be featured prominently at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las...
Boston Scientific to present late-breaking data at NANS 2024
Boston Scientific Corporation has announced its clinical data that will be featured at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January,...
Route 92 announces 100th patent for its neurovascular intervention portfolio
Route 92 Medical has announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio, as per a press release. The...
Neuralace announces US FDA clearance for Axon therapy ahead of NANS...
Neuralace Medical has announced the US Food and Drug Administration (FDA) clearance of its “groundbreaking” Axon therapy for the treatment of chronic painful diabetic...
No increased risk of complications found with transradial access for carotid...
Carotid artery stenting (CAS) delivered via transradial artery access has demonstrated no increased risk of stroke, death, myocardial infarction, transient ischaemic attack, or access...
Black people face strokes at higher rates and younger ages than...
In a recent study from the USA now published in the journal Neurology, Black people consistently had a higher rate of stroke than white...
Arissa Medical announces positive feasibility study results with Syntra intrasaccular scaffold
Arissa Medical has announced the successful evaluation of the Syntra intrasaccular scaffold system within simulated use conditions under fluoroscopy using clinically relevant, in-vitro intracranial...
Mentice gains US FDA 510(k) clearance for Ankyras software
Mentice recently announced that Ankyras, the company’s clinical decision support application, has received 510(k) clearance from the US Food and Drug Administration (FDA). The...
Newly published PROST trial results find Preset non-inferior to Solitaire in...
Final results from the PROST randomised controlled trial (RCT) have been published in JAMA Neurology and—according to the study’s leading investigators—provide evidence that thrombectomy...
Is it time to consider a paradigm shift from mechanical thrombectomy...
In light of recent evidence indicating that thrombectomies with poor reperfusion may lead to inferior clinical outcomes versus medical management in ischaemic stroke, Adrien...
Hyperfine launches AI-powered eighth generation of Swoop system software
Hyperfine has announced the launch of the artificial intelligence (AI)-powered eighth generation of its Swoop system software.
“The software update on the Swoop system has been...
“The third way” in intrasaccular aneurysm treatment demonstrates positive one-year outcomes
A device labelled “the third way” to potentially treat intracranial aneurysms via an intrasaccular approach has demonstrated positive effectiveness and safety results at one...
Question is “not if, but when” to stent in challenging, NET-rich...
The recent Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (4–6 December 2023, London, UK) saw Tommy Andersson (Karolinska University Hospital, Stockholm, Sweden) put...
Phil White
Phil White’s career as a physician and researcher has seen him play a role in numerous major stroke trials, and serve as an educator...
Axonics announces definitive agreement to be acquired by Boston Scientific
Axonics has announced that it has entered into a definitive agreement to be acquired by Boston Scientific Corporation for US$71 in cash per share,...
SynerFuse appoints Rohan Lall as chief medical officer
SynerFuse has announced the appointment of Rohan Lall (M Health Fairview Neurosurgery, Princeton, USA) as the company’s chief medical officer. The appointment was effective...
Rescue stenting shows good outcomes among Middle Eastern, African and Asian...
Rescue stent placement following a failed thrombectomy procedure has demonstrated “good outcomes” and a low risk of clinically significant bleeding in a multiethnic cohort...
Evasc announces clinical milestones and plans to expand European presence with...
Evasc Neurovascular has announced new strategic growth initiatives, having recently achieved a milestone of 120 successful cerebral aneurysm cases with its innovative Eclips device....
NeuroNews’ top 10 most popular stories of December 2023
Multiple new pieces of major trial data presented at the Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November 2023, Miami, USA)...
Global experts call for tighter standards to speed up emergency haemorrhagic...
An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for...
NeuroPace announces early completion of patient enrolment in NAUTILUS pivotal study
NeuroPace has announced the completion of the patient enrolment goal in its NAUTILUS pivotal study for the treatment of idiopathic generalised epilepsy (IGE) “more...
US neurointerventionists argue recent data “affirm” benefits of direct stroke triage
In an editor's column published recently in the Journal of NeuroInterventional Surgery (JNIS), leading members of the Society of NeuroInterventional Surgery (SNIS) have argued that the entire body...
Perfuze announces US FDA 510(k) clearances for novel aspiration and access...
Perfuze has announced US Food and Drug Administration (FDA) clearances for the Millipede 070 aspiration catheter and the second-generation of its Millipede 088 access...
Ischaemic stroke—we are all vulnerable
Conrad Yiu, a pioneer and visionary in interventional ischaemic stroke therapy, passed away in the final weeks of 2023, succumbing to the very disease for...
Researchers receive €10 million grant to create ‘digital twins’ in cerebral...
Researchers in The Netherlands have received a Horizon grant worth €10 million from the European Commission to accelerate development of a technology that could...
Recruitment in UK trial evaluating PreSize Neurovascular software reaches halfway point
Oxford Heartbeat has announced that its ongoing clinical impact trial of PreSize Neurovascular—a CE mark-certified, “first of its kind” for decision-support software in the field that...
Nicolab attains US FDA 510(k) clearance for CT perfusion algorithm
Nicolab has announced that its computed tomography (CT) perfusion algorithm, which is integrated into the company’s StrokeViewer platform, has obtained 510(k) clearance from the...
Former Stimwave CEO hit with fraud charges over ‘fake, non-functional’ device...
The US Securities and Exchange Commission (SEC) has today charged Laura Tyler Perryman—the former chief executive officer (CEO) and co-founder of Florida-based medical device...
INSPIRE-S registry offers comprehensive, real-world data on acute ischaemic stroke devices
This advertorial is sponsored by Medtronic.
As part of the company’s ongoing commitment to offering physicians access to high-quality clinical data and, subsequently, enabling evidence-based...
Washington state “poised” to extend spinal cord stimulation coverage following straw...
As per a recent statement from the North American Neuromodulation Society (NANS), the US state of Washington may be about to extend its insurance...
Imperative announces FIH study of device enabling single antiplatelet therapy after...
Imperative Care has announced the initiation of a first-in-human (FIH) clinical study for its novel stent system designed to only require single antiplatelet therapy...
APRO catheters offer ‘gold-standard’ trackability with robustness and stent-retriever compatibility to...
This advertorial is sponsored by Medtronic.
As the co-founder and chief executive officer of Chestnut Medical, Aaron Berez played a leading role in bringing flow...
MRI-equipped ambulances could help speed up acute stroke diagnoses and treatments
Researchers from the Medical University of South Carolina (MUSC) have partnered with US emergency medical services (EMS) to pilot test the first magnetic resonance...
NeuroOne receives US FDA 510(k) clearance to market OneRF ablation system
NeuroOne Medical Technologies Corporation has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its OneRF ablation system for...
Neuspera completes patient enrolment and implants for SANS-UUI pivotal clinical trial
Neuspera Medical recently announced it has completed patient enrolment and implant procedures for the SANS-UUI pivotal clinical trial of its Neuspera system—a discreet, minimally...
BCV secures €6 million in Series A funding round
BCV has announced that it has secured €6 million in a Series A round of financing led by Forepont Capital Partners, with other investors...
NeuroNews’ top 10 most popular stories of October/November 2023
Across October and November, our readers were drawn to everything from recent shifts in neurovascular device regulation, to “failures of the peer-review process” in...
Rapid announces Japanese approval and exclusive partnership with Kaneka for Tigertriever
Rapid Medical has announced Japanese approval for its Tigertriever revascularisation device. With Pharmaceuticals and Medical Devices Agency (PMDA) approval, Tigertriever serves as “the first...
INSPIRE-A registry helps pave way for standardised assessment of flow-diverter imaging...
This advertorial is sponsored by Medtronic.
As a prospective, independently adjudicated registry boasting a highly comprehensive patient dataset, INSPIRE-A is a “very unique” phenomenon in...
Philips enrols 100th patient in WE-TRUST study of direct-to-angio-suite approach
Philips has announced that, on 29 November 2023, the WE-TRUST study enrolled its 100th patient, marking what the company describes as an “important milestone”...
NeuroNews issue 52 – US
Highlights:
Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at...
NeuroNews issue 52 – OUS
Highlights:
Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at...
SpineX close to full recruitment for SCONE clinical trial
SpineX has announced that it is close to full recruitment of the patient cohort for a clinical trial of its proprietary SCONE device, recently...
Q’Apel Medical launches new-generation Hippo aspiration system for stroke thrombectomy
Q’Apel Medical has launched a new-generation aspiration technology, the 072 Hippo aspiration system, which has been developed for patients suffering from a stroke due...
New SOFAST data show high technical success and first-pass rates with...
Fresh data from the SOFAST study have indicated high rates of technical success and first-pass reperfusion with the Sofia 6Fr Flow Plus aspiration catheter...
Nevro announces acquisition of Vyrsa Technologies
Nevro Corporation has announced that it has acquired Vyrsa Technologies—a privately held medical technology company focused on a minimally invasive treatment option for patients...
Stroke thrombectomy gains approval from Brazilian health ministry in “historical milestone”
A “historical milestone” for stroke patients in Brazil was achieved recently, with the country’s Ministry of Health (MOH) publishing Order 1.996/2023 on 24 November...
Neurovascular OBLs: Business outcomes, patient outcomes, and reimbursement trends
This advertorial, sponsored by Siemens Healthineers and intended for US readers only, is part of a series of articles on the emerging role for...
Nalu announces positive results from spinal cord stimulation nPower US clinical...
Nalu Medical has announced the publication of the spinal cord stimulation (SCS) nPower US clinical study in the Pain Physician Journal, reporting on clinical outcomes...
Study finds “eye-opening” variability across physician estimations of flow-diverter deployment
A comparative study recently demonstrated the promise held by PreSize Neurovascular (Oxford Heartbeat) software in consistently and accurately making predictions about flow-diverter placement in...
Tenecteplase deemed a safe and feasible adjunct to thrombectomy in ALLY...
Intra-arterial tenecteplase has demonstrated potential as a safe and feasible adjunct to mechanical thrombectomy in patients with acute ischaemic stroke caused by a distal...
Newly published study shows preventative benefits of Nerivio wearable in adolescents...
Theranica has announced the peer-reviewed publication of a comprehensive clinical study showing the preventive benefits of its remote electrical neuromodulation (REN) wearable, Nerivio, for...
Understanding brain aneurysms: Prevalence, burden, and empowering patients
In a guest piece for NeuroNews, Arūnė Simanavičienė (Kaunas, Lithuania) and Audrius Širvinskas (Vilnius, Lithuania) highlight the work being done by the Brain Aneurysm...
Endovascular therapy under general anaesthesia linked to improved functional outcomes versus...
The multicentre, randomised SEGA trial has found that acute ischaemic stroke patients who receive endovascular therapy (EVT) under general anaesthesia experience better functional outcomes...
Apotransferrin shows promise in animal models of intracranial haemorrhage
Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH)...
Mobile stroke units increase odds of averting strokes and achieving complete...
Receiving intravenous tissue plasminogen activator (IV-tPA) in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and the odds of a...
Brainomix targets US expansion following launch of 360 platform at SVIN...
Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its...
Nevro announces “profound improvements” in non-surgical refractory back pain patients treated...
Nevro Corporation has announced the publication of new 24-month data from the SENZA-NSRBP multicentre randomised controlled trial (RCT) in the Journal of Neurosurgery: Spine. The...
Route 92 raises more than US$31 million in oversubscribed Series F...
Route 92 Medical has announced it has raised more than US$31 million in a Series F financing round to accelerate the commercial adoption of...
Neurolutions and Kandu partner to accelerate access to improved stroke rehabilitation
Neurolutions and Kandu Health recently announced a strategic partnership intended to raise the standard of care for post-stroke recovery. Through this partnership, Kandu’s expert...
Boston Scientific expands neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous...
Tenecteplase deemed non-inferior to alteplase in suitable ischaemic stroke patients
The ATTEST-2 trial has found that tenecteplase was non-inferior to alteplase, the more established of the two thrombolytic agents, in suitable acute ischaemic stroke...
Tigertriever device produces high treatment-success rate in challenging ICAD stroke patients
Rapid Medical has announced new data demonstrating “excellent” first-pass treatment success using the Tigertriever device in complex ischaemic stroke patients with underlying intracranial atherosclerotic disease (ICAD)....
Microvention celebrates 10 years and more than 500,000 procedures with Sofia...
Microvention, a wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of its Sofia and Sofia Flow...
Route 92 announces positive clinical findings with Tenzing 7 delivery catheter
Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a...
Current intracranial aneurysm literature reflects “a failure of the peer-review process”
A systematic review and meta-analysis of 1,356 studies and more than 410,000 patients have found that “methodological flaws and incomplete reporting” occur frequently in...
Evolving the standard of care: What is next for functional neurosurgery?
The proliferation of new technologies and advancements in the neurosciences space has showed little sign of slowing in recent years and—as John Rolston (Boston,...
CX 2024: New technologies and “special cases” underpin carotid and acute...
With a renewed focus on challenging cases, novel technologies and, overall, the most pressing issues in carotid treatments and acute stroke care, the 2024...
Patients in lower socioeconomic status areas less likely to receive acute...
People who live in neighbourhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo mechanical thrombectomy procedures after they have...
SpineX announces new report on SCS improving bladder function in stroke...
SpineX has reported in a press release that a publication titled, “A pilot study of the effect of transcutaneous spinal cord stimulation on micturition-related...
RapidAI receives US FDA clearance of AI module for detecting hemispheric...
RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection...
Rapid Medical announces enrolment of final patient in post-market SUCCESS study
Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the...
Medical necessity “should drive all remote monitoring decisions” in SCS, expert...
The principle of medical necessity “should drive all remote monitoring decisions” relating to spinal cord stimulation (SCS) technologies, according to recommendations recently published in...
Surgical Information Sciences initiates VISION study to support DBS for Parkinson’s...
Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus...
Perfuze enrols first stroke patient in MARRS pivotal trial of Millipede...
Perfuze has announced commencement of enrolment in its pivotal MARRS study—a multicentre trial set to evaluate the performance of aspiration thrombectomy with the company’s...
InspireMD presents positive 30-day follow-up results from C-GUARDIANS clinical trial
InspireMD recently presented 30-day results from the C-GUARDIANS US investigational device exemption (IDE) clinical trial evaluating its CGuard embolic prevention stent (EPS) system for...
TENSION results show improved functional outcomes and reduced mortality with stroke...
New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center...
Contego announces low one-year stroke rates in PERFORMANCE II carotid stent...
Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular Interventional Advances (VIVA)...
Annalise.ai launches comprehensive radiology triage suite for chest X-ray and head...
Annalise.ai has announced the launch of Annalise Triage—an innovative software solution tailored specifically for the US market that the company claims will “transform the...
NICO highlights study showing “first ever” successful deep-brain BCI implantation in...
A study demonstrating the successful deep-brain placement of a brain-computer interface (BCI) microchip into a living animal with no apparent neurological effects has been...
SVIN 2023 to champion innovation and inclusivity in “notable departure” from...
In a “notable departure” from prior iterations of the conference, this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November, Miami,...
PROST represents “epitome” of scientific rigour, but future trials may follow...
There are multiple components of the PROST randomised controlled trial’s (RCT) design that set it apart from prior studies and make it somewhat unique...
Surmodics launches Preside hydrophilic coatings for neurovascular, coronary and peripheral applications
Surmodics has announced the commercial launch of its most advanced hydrophilic medical device coating technology, the Preside hydrophilic coatings.
As per a company press release,...
MindRhythm receives US FDA breakthrough designation for Harmony headset
MindRhythm has announced that the US Food and Drug Administration (FDA) has awarded a Breakthrough Device designation to its Harmony headset embedded with HeadPulse...
No relationship found between DW-MRI lesions and long-term stroke risk following...
A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid...
Case report details “promising” first use of bilateral cerebellar rTMS to...
In a new case report, researchers at University of California Los Angeles (UCLA) Health have described “promising results” using repetitive transcranial magnetic stimulation (rTMS)...
Latest TRIAGE-STROKE and RACECAT data put the brakes on alternative stroke...
Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or...
Cordance gains US FDA breakthrough designation for NeuroAccess technology
Cordance Medical has announced that its device, NeuroAccess, has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA), meaning the...
Physicians highlight that “stroke strikes at any age” ahead of World...
Ahead of World Stroke Day 2023, on 29 October, physicians from the Get Ahead of Stroke campaign are highlighting the fact that, while prevalence...
EOSolutions receives US FDA clearance for Thinline introducer sheath
EOSolutions Corporation has announced that the US Food and Drug Administration (FDA) has cleared its Thinline introducer sheath—an approval that swiftly follows the successful...
Cognito announces 18-month data showing durability of gamma sensory stimulation for...
Cognito Therapeutics has announced that continued active treatment with the company’s gamma sensory stimulation technology in the Phase 2 OVERTURE open label extension (OLE)...
Butterfly Network and Forest Neurotech to partner on development of next-generation...
Digital health company Butterfly Network and deep tech research firm Forest Neurotech announced yesterday that they have entered into a five-year co-development agreement to...
Upcoming technologies set to forebear “new era” in prehospital stroke care
While the latest thrombectomy techniques, thrombolytic drug candidates and even neuroprotective agents are the source of much discussion in today’s neurovascular space, there is...
Researchers develop non-surgical DBS technology capable of boosting memory accuracy
Researchers at the UK Dementia Research Institute (DRI) have developed a new form of deep brain stimulation (DBS) that does not require surgery and...
Smart ‘brain-wave cap’ could help diagnose stroke patients accurately in ambulances
A specialised ‘brain-wave cap’, designed by researchers in The Netherlands, may be able to diagnose stroke patients while they are in an ambulance—thus allowing...
Robocath completes CARE clinical trial evaluating robotic carotid stenting
Robocath has today announced the results of its CARE clinical trial focusing on robotic carotid stenting—the first phase of a research programme launched in...
SynerFuse completes enrolment in proof-of-concept study
SynerFuse has announced that it has completed enrolment in its proof-of-concept study to evaluate the safety and tolerability of the Electric Transforaminal Lumbar Interbody...
Expert roundtable devises roadmap on fatigue, mobility, brain stimulation and research...
The third Stroke Recovery and Rehabilitation Roundtable—an initiative of the International Stroke Recovery and Rehabilitation Alliance (ISRRA)—has made a series of key recommendations about...
Current evidence on AI-based autonomous interventions “inadequate” despite potential benefits
The existing body of evidence supporting artificial intelligence (AI) and the autonomous navigation of endovascular procedures is “inadequate”, despite the theoretical benefits held by...
Bilateral cerebellar rTMS represents “promising” treatment option for post-stroke dysphagia
Administering 10Hz cerebellar repetitive transcranial magnetic stimulation (rTMS) offers a “promising”, non-invasive treatment option in patients experiencing dysphagia following a subacute infratentorial stroke, as...
Anaconda Biomed granted additional patents for novel stroke thrombectomy technology
Anaconda Biomed has announced that the European Patent Office has granted the company a European patent for “A device and a thrombectomy apparatus for...
New data suggest faster and less costly thrombectomy procedures with Zoom...
Imperative Care recently announced the publication of clinical data in the journal Interventional Neuroradiology (INR) detailing the use of its Zoom aspiration catheters in...
Athersys announces ‘disappointing’ results from MASTERS-2 interim analysis
Athersys has announced that the independent data safety monitoring board (DSMB) has completed a preplanned interim analysis of the company’s ongoing, phase three MASTERS-2...
“The tables have turned”—US FDA regulation is becoming the envy of...
Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) revealed the extent of the disparities between the...
Nautilus represents “next evolution” of intrasaccular systems in aneurysm care
The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular...
Boston receives expanded US FDA approval of SCS therapy for painful...
Boston Scientific has announced that the US Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha spinal cord stimulator...
Brainomix and Nanoflex to work on AI-assisted robotic system for remote...
Brainomix and Nanoflex Robotics have announced today that they have been awarded a grant via the ‘UK—Switzerland Bilateral: Collaborative R&D ’ programme, under which...
Rates of stroke, death and myocardial infarction post-TCAR do not differ...
While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery...
Newly published data indicate NovaGuide system can outperform standard of care...
NeuraSignal has announced the publication of positive results from the BUBL clinical study supporting the safety and superior performance of its NovaGuide intelligent ultrasound...
Philips partners with WSO to improve access to high-quality stroke care...
Royal Philips and the World Stroke Organization (WSO) have announced the signing of a two-year partnership aimed at improving access to high-quality stroke care.
Building...
Hyperfine gains US FDA clearance for AI-powered software update of Swoop...
Hyperfine has announced US Food and Drug Administration (FDA) clearance of updated software for its portable magnetic resonance brain imaging technology, the Swoop system....
WSO predicts 50% more deaths unless “catastrophic” gaps in global stroke...
Between now and 2050—unless “urgent action is taken”—the number of people who die from stroke globally is estimated to increase by 50%, to 9.7...
Contego announces enrolment of first patient in PERFORMANCE III trial
Contego Medical has announced enrolment of the first patient in the prospective, multicentre PERFORMANCE III trial aimed at further evaluating the safety and effectiveness...
NeuroNews’ top 10 most popular stories of September 2023
Exclusive interviews with multiple pioneering figures in the US neurovascular field earmark NeuroNews’ latest top 10, as do results from two ongoing studies attempting...
Biotronik announces new data supporting effectiveness of RESONANCE multiphase stimulation paradigm
Biotronik Neuro has announced that results from the BENEFIT-02 trial—the “first of its kind” to clinically evaluate a multiphase stimulation paradigm—support the effectiveness of...
‘Surprising’ regional variations in subarachnoid haemorrhage care revealed by Finnish study
A study recently published in the journal Neurology investigated whether there are discrepancies in the prognosis of subarachnoid haemorrhage (SAH) patients between the university hospital...
Medtronic names Paolo Di Vincenzo president of its neuromodulation business
Medtronic has shared that Paolo Di Vincenzo will join the company as president of its neuromodulation business, effective 30 October 2023. In this role,...
NANS leads multi-society response to “methodologically flawed” SCS re-review in Washington...
The North American Neuromodulation Society (NANS) has led a multi-society response to the Washington State Health Care Authority (WSHCA) following its review of the...
Reduced complications and patient satisfaction among key benefits of radial access
Transradial access, whereby the vasculature is navigated to via the radial artery in the wrist, has been a topic of much debate in the...
Research shows “direct mechanistic link” between COVID-19 infection and heart attack,...
A new study has shed fresh light on the potential connection between pre-existing heart issues and symptoms of ‘long-COVID’. According to researchers from New...
Striving for more distal guide-catheter placement is a “no-brainer” in stroke...
This advertorial, intended for US readers only, is sponsored by CERENOVUS.
“Going distally with guide catheters is more routine nowadays,” says Violiza Inoa (Memphis, USA),...
Young neurosurgeon awarded US$150,000 to study higher cerebral aneurysm rate in...
A young neurosurgeon and researcher from Buffalo, USA has been awarded US$150,000 via the Congress of Neurological Surgeons (CNS) Foundation/Cerebrovascular (CV) Young Investigator Grant...
Remote teleproctoring helps neurointerventionists overcome wartime restrictions in Ukraine
Remote teleproctoring has demonstrated promising results in providing hands-on mechanical thrombectomy training and overcoming wartime migration restrictions in Ukraine, according to initial experiences published...
NeuroNews issue 51 – US
Highlights:
New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from...
NeuroNews issue 51 – OUS
Highlights:
New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from...
Recent breakthroughs represent “baby steps” towards wider use of brain-computer interfaces
“The possibility to restore mobility to patients could have tremendous benefits,” says Mitchell Elkind, chief clinical science officer of the American Heart Association (AHA),...
Cerevasc announces multiple data presentations from CNS 2023
Cerevasc has announced that data from clinical studies examining the use of its eShunt system to treat elderly patients with normal-pressure hydrocephalus, and patients with...
Saluda receives US FDA approval for MRI labelling of Evoke spinal...
Saluda Medical has announced that the US Food and Drug Administration (FDA) has approved magnetic resonance imaging (MRI) conditional labelling for its Evoke system,...
Onward announces first-in-human implant of ARC-IM stimulator with wireless BCI device
Onward Medical has today announced the successful first-in-human implant of its ARC-IM stimulator intended to restore upper-extremity function after spinal cord injury (SCI). The...
US Brain Aneurysm Foundation announces 2023 research grants
The Brain Aneurysm Foundation (BAF) has announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or...
New AVM intervention findings “refute” ARUBA complication rates and may elicit...
New data from an analysis of patients who would have been eligible for the ARUBA trial—which previously indicated medical management is likely favourable over...
Young endarterectomy patients more likely to experience restenosis and late neurological...
Data from the US Vascular Quality Initiative (VQI) have indicated that younger patients (aged ≤55 years) who undergo a carotid endarterectomy (CEA) procedure face an...
Cerevasc announces US FDA-approved expansion of normal-pressure hydrocephalus study
Cerevasc has announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of...
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Insights from interventional neuroradiologists on coping with severe complications
Given the potentially devastating consequences that can occur if an ischaemic stroke or acute intracranial aneurysm procedure goes wrong, an interventional neuroradiologist’s practice is...
Nevro announces new data demonstrating health economic benefits of 10kHz SCS...
Nevro Corporation has announced the publication of new data validating the health economic benefits of 10kHz therapy, the company’s proprietary, high-frequency spinal cord stimulation...
Microvention enters transradial access market with US FDA clearance of Sofia...
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the Sofia EX 5Fr 115cm intracranial support catheter received US Food and Drug...
AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...
ASA seeks to ‘empower’ Hispanic-Latino communities with promotion of RÁPIDO acronym
To help “close the gap between knowledge and action”, the American Stroke Association (ASA) is launching a culturally relevant Spanish-language campaign named ‘Juntos Contra...
Motif conducts first-in-human research of pea-sized brain stimulator for treatment-resistant depression
Motif Neurotech, a company developing minimally invasive bioelectronics for mental health conditions, has announced new research published to the preprint server Medrxiv that demonstrates the use...
Route 92 Medical announces appointment of Jonathan Kennedy as chief financial...
Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible...
Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...
Cerevasc announces presentation of initial eShunt data at ESMINT 2023
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented...
Theranica announces new study indicating meaningful impact of Nerivio from as...
Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only...
New Pathway to Neurosurgery programme intends to “open doors” for underrepresented...
The Congress of Neurological Surgeons (CNS) Foundation has launched its Pathway to Neurosurgery programme, an initiative dedicated to alleviating healthcare disparities by encouraging high...
Brain Aneurysm Foundation launches ‘Stop the Pop’ campaign
The Brain Aneurysm Foundation (BAF) has announced the launch of ‘Stop the Pop’—a new campaign intended to increase awareness of the prevalence and impact...
NeuroNews’ top 10 most popular stories of August 2023
Several presentations and news stories from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) ended up among...
Synchron completes enrolment in US COMMAND trial of endovascular brain-computer interface
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to...
‘Minimal differences’ in clinical outcomes between stroke thrombectomy with or without...
There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy...
Intrathecal drug delivery effective for managing cancer-related pain, as per existing...
Two separate systematic reviews and meta-analyses—both published recently in Neuromodulation: Technology at the Neural Interface—have concluded that intrathecal drug delivery (IDD) systems are effective...
Observation, creativity and happy accidents: Transitioning from clinical life to industry...
When it comes to advising young physicians on how to navigate the more commercial, industry-entwined commitments that their career will most likely bring further...
The physics of aspiration thrombectomy—what matters?
This advertorial, intended for readers outside the USA only, is sponsored by Penumbra.
Much of the clinical success that can be achieved with aspiration-based mechanical...
Old but still gold—why coiling remains a vital tool for treating...
This advertorial is sponsored by Medtronic.
Alberto Nania (National Health Service Lothian, Edinburgh, UK) speaks to NeuroNews to outline how, despite the rapid proliferation...
EVT with poor reperfusion linked to worse outcomes than medical management...
Endovascular therapy (EVT) treatments that achieve poor reperfusion have been found to result in inferior clinical outcomes compared to best medical management (BMM) in...
Rapid gains Chinese NMPA regulatory approval for Tigertriever thrombectomy device
Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer...
Ameer Hassan
Having initially sought out a career in plastic surgery, Ameer Hassan (Harlingen, USA) switched gears to interventional neurology in 2005—a change of heart he...
Mainstay Medical announces completion of US enrolment in RESTORE clinical trial
Mainstay Medical has announced the completion of enrolment in its RESTORE randomised clinical study of ReActiv8 for the treatment of intractable chronic low back...
Novel ‘infraslow pink noise’ stimulation found to be safe and feasible...
A novel brain stimulation technique called high-definition transcranial infraslow pink noise stimulation (HD-tIPNS) was recently evaluated in a placebo-controlled pilot study, and found to...
Brain Navi to showcase NaoTrac and KrystoLens neurosurgical devices at upcoming...
Brain Navi has announced the demonstration of NaoTrac, a neurosurgical navigation robot, and KrystoLens, a single-use neuro-endoscope, at two upcoming conferences: the Congress of Neurological...
Two-year data indicate long-term effectiveness of Nevro’s SCS therapy in painful...
Nevro Corporation recently announced the publication of 24-month data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—the largest RCT to evaluate...
Mahesh Jayaraman becomes 28th president of the Society of NeuroInterventional Surgery
Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the...
Medtronic receives CE-mark approval for Inceptiv closed-loop SCS to treat chronic...
Medtronic has received CE-mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator in the treatment of chronic pain.
Inceptiv is the first Medtronic spinal...
Case series indicates effectiveness of direct-current stimulation in multiple sclerosis patients
A case series conducted by Courtney Ellerbusch (Centura Home Health, Colorado, USA) on multiple sclerosis (MS) patients has found quantitative improvements in strength, spasticity,...
Biomarker-guided neuromodulation alleviates memory loss in traumatic brain injury patients
A collaborative study published in the journal Brain Stimulation has shown that targeted electrical stimulation in epilepsy patients with traumatic brain injury (TBI) can...
Continued improvement of flow diverters and intrasacculars holds key to truly...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...
Missing outcome data is common and ‘does not occur at random’...
The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely...
Massachusetts’ stroke triage updates will save lives and reduce disability, says...
Massachusetts patients experiencing stroke could soon have access to refined treatment, triage and transport protocols based on a provision in the US state’s new...
Nurami receives US FDA 510(k) clearance for resorbable dural repair graft
Nurami Medical, a medical device startup company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its electrospun nanofibre-based product, ArtiFascia...
Hubly cranial access drill compares favourably to established device in safety...
Hubly Surgical has announced the results from the first peer-reviewed study comparing the safety and efficacy of its recently US Food and Drug Administration...
Enspire announces publication of trial evaluating DBS plus rehab for stroke...
Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing...
US FDA grants de novo marketing request to BlueWind’s Revi system...
BlueWind Medical has announced that the US Food and Drug Administration (FDA) has granted a de novo marketing request for the Revi system—a “transformative”...
Kandu announces positive functional outcomes and low readmission rates in novel...
Kandu Health has announced preliminary outcomes from the first 40 stroke survivors served by its novel stroke recovery programme, which intends to support stroke...
US registry study reveals 75% of acute stroke patients wait more...
A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than...
Hyperfine completes enrolment for pilot study assessing portable MRI in paediatric...
Hyperfine has announced completed enrolment for HOPE PMR—a multicentre, observational pilot study assessing portable magnetic resonance imaging (MRI) in children with neurological injury, using...
Flow announces pivotal trial results indicating tDCS headset is twice as...
Flow Neuroscience, the creator of the Flow transcranial direct current stimulation (tDCS) headset for at-home, non-invasive brain stimulation to treat depression, has announced the...
Imperative unveils new company structure intended to elevate stroke and vascular...
Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this...
NeuroNews’ top 10 most popular stories of July 2023
NeuroNews’ 10 most popular stories from July reveal a huge amount of interest in the treatment of stroke patients with medium vessel occlusions (MeVOs)—with...
Health economic data show cost-dominance of Saluda’s EVOKE system over open-loop...
Saluda Medical has announced the publication of new health economic data in the Clinical Journal of Pain that provides “the strongest ever economic case” for the...
Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...
Systematic review and meta-analysis find stroke thrombectomy safe and effective in...
A study presented at last week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) noted that mechanical thrombectomy—in...
‘Care hotel’ model can lower costs and shorten hospital stays after...
Using a ‘care hotel’ model, which discharges patients to a specialty hospital hotel after smaller surgeries, can lower costs and shorten patients’ time in...
Enspire announces US$17.6 million Series B financing to advance DBS plus...
Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations....
Anuncia announces first successful implant of ReFlow mini flusher in hydrocephalus...
Anuncia Medical has announced the successful first implant of the company's US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device.
Performed on by neurosurgeon Samuel...
Imperative announces late-breaking data showing benefits of ‘angled-tip’ aspiration catheters
Imperative Care has announced late-breaking data from the Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) evaluating its Zoom stroke solution, which were presented at the...
Kernel unveils new Flow2 advancing neuroimaging system
Kernel has unveiled its Flow2 system, which the company claims will give researchers and clinicians “unprecedented access” to robust, functional magnetic resonance imaging (fMRI)-like...
Smartphone app reliably and autonomously recognises physical stroke signs in study
During a late-breaking abstract session at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA), researchers discussed a...
New study finds surgical approaches safe and effective in ARUBA-eligible unruptured...
Contrary to the results of a seminal study in the field, a recent analysis presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting...
Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology
Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of...
Less invasive ‘liquid biopsy’ holds potential to identify genetic mutations in...
A study presented yesterday at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that it may be...
EOSolutions announces 510(k) submission of Thinline 8Fr vascular access sheath
EOSolutions has announced the US Food and Drug Administration (FDA) 510(k) submission, through a design consulting firm, of the Thinline 8Fr sheath—a vascular access solution...
New data indicate clinical benefits of Imperative’s Zoom stroke solution in...
Imperative Care has announced multiple new pieces of data from studies evaluating its Zoom stroke solution, presented at the ongoing Society of NeuroInterventional Surgery...
Aidoc launches AI-powered Full Brain solution to “significantly expand” stroke detection
Aidoc has announced the launch of its “revolutionary” Full Brain solution, which the company claims will significantly expand the anatomy analysed by artificial intelligence...
Study indicates filter-tip stent retrievers may improve first-pass thrombectomy rates
Research presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has shown that different types of...
Microvention announces five-year WEB-IT data alongside two new device sizes
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two...
New eligibility criteria including large-core strokes could boost thrombectomy rates “dramatically”
A study presented on the first day of the 2023 Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has...
Neurovascular OBLs: Enhancing patient satisfaction and accessibility with advanced biplane systems
This advertorial, sponsored by Siemens Healthineers, is intended for US readers only.
A neurosurgical clinic in Raleigh, USA recently opened an office-based lab (OBL)—specifically, the...
Early administration of antiplatelets may improve post-thrombectomy outcomes in stroke patients
Administering antiplatelet medication within 24 hours of a mechanical thrombectomy procedure may help stroke patients recover more successfully and prevent high-risk individuals from experiencing...
Route 92 announces publication of first-in-human study featuring FreeClimb 70 reperfusion...
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology....
Non-invasive VNS approach could enhance post-stroke recovery outcomes
A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies.
A paper published...
Mainstay announces publication of three-year data from post-market follow up of...
Mainstay Medical recently announced the publication of three-year clinical data from the post-market clinical follow-up (PMCF) study of 33 ReActiv8 patients at five medical...
Anuncia announces US launch of second-generation ReFlow device to treat hydrocephalus
Anuncia Medical has announced the successful US commercial launch of the ReFlow mini flusher—a second-generation device for the treatment of hydrocephalus. According to a...
Elevating stroke care: Navigating the transition from primary to comprehensive centres
In a guest piece for NeuroNews, Thomas Devlin (Chattanooga, USA) and Michelle Luffey advise the community on how best to navigate the transition from...
Nicolab and Titan partner to improve prehospital workflows in acute stroke
Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines...
Hubly Surgical closes oversubscribed US$3 million seed funding round
Hubly Surgical has successfully closed its Series seed funding round at an oversubscribed US$3 million. As per a company announcement, this investment comes on the...
Nalu presents new study data on pain management with PNS and...
Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal...
Imperative gains US FDA clearance for Zoom 88 support and announces...
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 88 large distal platform (LDP) support, a portfolio expansion...
Arsenal Medical announces treatment of first patient with NeoCast embolic biomaterial
Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions.
The patient was successfully...
Recruitment in iVascular’s SEMTIC study passes halfway point
iVascular has announced that the SEMTIC study, evaluating the safety and efficacy of its comprehensive stroke thrombectomy treatment, is one step closer to providing...
“No significant difference” between aspiration and stent-retriever thrombectomy in medium vessel...
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...
Insightec gains US FDA nod for five-year endpoint in MR-guided focused...
Insightec has announced US Food and Drug Administration (FDA) approval of the five-year study endpoint for what it claims is the largest prospective, long-term...
Magnus announces first treatments in OLO clinical trial of novel depression...
Magnus Medical has announced that the first participants have been treated in the Open Label Optimisation (OLO) clinical trial evaluating the effectiveness of the...
‘Intelligent suit’ supported by AI and electrical stimulation could enhance spinal...
Experts in Germany are working on an ‘intelligent suit’ with which they hope to significantly improve rehabilitation after a serious spinal cord injury. This...
Researchers develop geometric deep learning model with potential to more accurately...
Researchers in Germany have developed a new deep learning model for detecting stroke lesions, claiming that—by leveraging rich geometric information to segment brain stroke...
Interim analysis of MOOD trial produces positive neuromodulation data in depression...
Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel...
Rapid Medical announces new data showing “significant advantages” of Comaneci for...
Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured...
Flow-diverter performance “comparable” between PComAs and other supraclinoid aneurysms
The concluding findings of a systematic review and meta-analysis published in the journal Neurosurgery indicate that flow-diverter performance in posterior communicating artery (PComA) aneurysms...
Cognito presents MRI data showing efficacy of non-invasive gamma stimulation therapy...
Cognito Therapeutics has announced “robust, lobe-specific” changes in white matter volume and myelination in Alzheimer’s disease patients following six months of non-invasive gamma stimulation...
Education and collaboration key to continued advancement of painful diabetic neuropathy...
The neuromodulation space has proliferated significantly over the past few years, and one area in which this is most notable is with the expansion...
First US and French patients enrolled in Philips’ WE-TRUST study
Royal Philips has today announced enrolment of the first patients in both the USA and France into the large-scale WE-TRUST study—a multicentre, prospective randomised...
Research indicates women are less likely to be routed to comprehensive...
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centres (CSCs), women with large vessel occlusion (LVO) acute ischaemic stroke...
Craniotomy and decompressive craniectomy achieve similar outcomes in acute subdural haematoma
The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a...
Evren Technologies launches Phoenix 100 system for vagus nerve stimulation research
Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool.
The Phoenix 100 system is intended...
US centre achieves 87% drop in neurosurgical infection rates across two-year...
A US centre has achieved a steep drop in infection rates among its neurosurgery patients over a two-year period thanks to the implementation of...
Stryker announces commercial launch of Q guidance system with cranial guidance...
Stryker has commercially launched its Q guidance system with cranial guidance software to provide surgeons with an image-based planning and intraoperative guidance system that assists...
Flexible nanoelectrodes can “pave the way” for higher-resolution stimulation devices
Engineers at Rice University (Houston, USA) have created nanoelectrodes that are minimally invasive and exceptionally flexible—and, as such, have the potential to function as...
Hyperfine launches international study to assess Swoop system in stroke diagnosis...
Hyperfine, the company that created the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging...
Is thrombectomy set to become the standard of care for medium...
With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes...
ZAP-X gyroscopic radiosurgery platform gains Chinese NMPA approval
ZAP Surgical Systems has announced that the company has received National Medical Products Administration (NMPA) approval in China for its ZAP-X gyroscopic radiosurgery platform.
ZAP-X...
Zeta Surgical announces successful first treatment in neurosurgical navigation study
Zeta Surgical has successfully treated its first patient using the Zeta cranial navigation system as part of a first-in-human trial at the National Neuroscience Institute (NNI)...
Append Medical raises US$4.35 million in initial closing of extended series...
Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator.
Investors include...
“Definitive trial” needed to confirm desmopressin’s potential in ICH patients receiving...
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the...
Highly targeted brain stimulation achieves “very exciting” outcomes in acute ischaemic...
Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University...
NeuroNews’ top 10 most popular stories of June 2023
In addition to a number of key study presentations from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), NeuroNews’ most popular stories...
MindRhythm announces first patient enrolment in pivotal study of novel stroke-detection...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), recently announced that the first patient has been enrolled in the pivotal...
Researchers uncover ‘mutant origin’ of intracranial aneurysms and report promising drug...
Researchers at the RIKEN Center for Brain Science (CBS) in Wako, Japan have discovered a set of related mutations that lead to intracranial aneurysms....
Nerivio neuromodulation therapy found to safely treat migraine in pregnant women
Theranica has announced the results of a study recently published in the journal Headache demonstrating the safety of its Nerivio device—a novel remote electrical...
LINNC 2023 examines neuroprotection, steerable microcatheters and other ‘next frontiers’
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC...
First SynerFuse procedure performed by solo surgeon in two-level spinal fusion...
SynerFuse has announced that—for the first time in the world, it claims—a solo spine surgeon has performed the SynerFuse procedure in a two-level spinal...
New ENRICH-PLUS study set to build on recent positivity in haemorrhagic...
Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000...
Microvention announces commercial availability of ERIC retrieval device in the USA
Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having...
Black patients nearly 50% less likely to receive revascularisation for PAD
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of...
InspireMD announces completed enrolment in C-Guardians US IDE trial
InspireMD today announced that it has completed enrolment of its ongoing C-Guardians US Investigational Device Exemption (IDE) clinical trial, designed to support potential US...
US and Chinese experts introduce new aneurysmal subarachnoid haemorrhage guidelines
Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded...
LivaNova announces randomisation of 150th bipolar depression patient in RECOVER clinical...
LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating...
J Mocco
As president of the Society of NeuroInterventional Surgery (SNIS), endovascular neurosurgeon J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) has...
AptaTargets announces publication of APRIL trial data in JAMA Neurology
As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy...
Cochrane Library urged to retract and revise recent SCS review over...
Pain physicians have urged the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) in the treatment of low...
Sensome and Asahi Intecc partner to further development of Clotild smart...
Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role...
Incomplete imaging of transient ischaemic attack increases subsequent stroke risk
Transient ischaemic attacks (TIAs) encountered with incomplete neurovascular imaging in emergency departments (EDs) have been associated with higher odds of subsequent stroke within 90...
Kandu Health appoints new CEO and enrols first 50 patients in...
Imperative Care recently announced the appointment of Kirsten Carroll as the new CEO of Kandu Health—a digital health startup with the aim of improving quality...
Analysis shows substantial cost saving can be achieved with Philips’ DTAS...
Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the...
Vision recovery among potential benefits of endovascular therapy in PCA occlusion...
A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased...
Combined neuroprotection therapy shows promise in experimental stroke model
A new study conducted by scientists at Louisiana State University (LSU) Health New Orleans Neuroscience Center of Excellence (New Orleans, USA) reports that the...
Researchers identify novel protein linked to ischaemic stroke risk in older...
By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be...
Imperative announces data demonstrating benefits of Zoom RDL system in neurointerventional...
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial...
Precision Neuroscience begins first-in-human study of implantable BCI technology
Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed....
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
New study elucidates exact location of atherosclerotic plaque ruptures in carotid...
While the exact location of atherosclerotic plaque ruptures—a common cause of myocardial infarction (MI) and stroke—has previously been unknown, researchers at Lund University (Lund,...
NeuroNews’ top 10 most popular stories of May 2023
While a handful of our highlights from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) unsurprisingly feature in NeuroNews’ most-read stories through...
MAGNA meta-analysis further supports clinical benefit of EVT in large-core infarct...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic...
Early Feasibility Study programme has potential to advance US neurovascular space
At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation...
Anuncia announces publication of “promising” hydrocephalus outcomes with ReFlow ventricular system
Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus...
Nalu Medical announces first enrolment in peripheral nerve stimulation RCT
Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS)...
Combined thrombectomy technique fails to demonstrate superiority over aspiration alone
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...
NeuroNews issue 50 – US
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...
NeuroNews issue 50 – EU
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...
TESLA trial misses primary endpoint but exhibits “strong suggestion” favouring endovascular...
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion”...
Penumbra expands computer-aided thrombectomy offering with Lightning Bolt 7 launch
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Bolt 7, which the company claims is the most...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
First surgical cases underway using Stryker’s Q guidance system with cranial...
Stryker has announced that Early Product Surveillance (EPS) cases utilising its Q guidance system with cranial guidance software are underway. The technology provides surgeons with...
IRIS data shed new light on how treatment delays may impact...
A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT...
Nicolab awarded three-year contract to supply AI-powered stroke software in Australia
Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine...
EOSolutions announces full commercial launch of Dr Banner balloon guide catheter
EOSolutions Corporation has announced the introduction of the Dr Banner balloon guide catheter (BGC), which boasts “unmatched features” for neurovascular procedures. As per a...
Performance feedback significantly reduces door-to-groin time in endovascular therapy
Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving...
Brain-computer interface plus SCS therapy enables thought-controlled walking after spinal cord...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy....
“Sonolysis is back” after safely reducing endarterectomy stroke risk in randomised...
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
NeuroOne announces first clinical case using Evo sEEG electrode in robotic...
NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery.
Performed by William Bingaman at Cleveland Clinic in Cleveland,...
Pipeline Flex embolisation device deemed safe and effective in complex intracranial...
A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial...
Artiria granted US FDA clearance for real-time, deflectable guidewire
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug...
Interim data find “no evidence of benefit” for carotid revascularisation additional...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
New data represent “fantastic news” in IVT despite lack of efficacy...
Results from the TIMELESS trial represent “fantastic news” on the safety of intravenous tenecteplase in selected late-window stroke patients, despite the drug failing to...
Structured ambulatory post-stroke care “requires further evaluation” following mixed trial results
While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors...
STRIVE-2 neuroimaging standards provide “unique focus” on small vessel disease research
In an attempt to promote more consistent and higher quality research in the field of small vessel disease (SVD), international experts have published the...
Remote ischaemic conditioning fails to improve functional outcomes in acute stroke...
As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes...
Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke...
AI tool outperforms human emergency call handlers in identifying stroke
A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by...
WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
Open and endovascular surgery recommended over ligation in ruptured extracranial carotid...
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms....
ChatGPT outperforms medical students and matches residents on neurosurgical board-style questions
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the...
Abbott gains US FDA nod to treat non-surgical back pain with...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic...
AHA: Systemic interventions key to tackling “enormous inequities” in stroke care
‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not...
RapidAI wins MedTech Breakthrough award for best new imaging solution
RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the...
Magnus shares study results indicating SAINT depression treatment changes abnormal brain...
Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation...
Office-based removal of sacral neuromodulation devices deemed safe and well-tolerated
As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a...
Carthera publishes “promising” results with SonoCloud-9 in glioblastoma patients
Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University...
MR CLEAN-LATE trial finds endovascular therapy safe and effective in late-presenting...
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present...
Abbott announces expanded MRI labelling for Eterna spinal cord stimulation system
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its Eterna spinal cord...
European Academy of Neurology launches collaboration to address global brain disorder...
Earlier this week, the European Academy of Neurology (EAN) announced the launch of the Brain Health Mission, a collaborative initiative that aims to address...
‘We need better tools’—new intracranial stent devices required for rare stroke...
“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a...
Hubly Surgical gains US FDA clearance for novel burr-hole placement device
Hubly Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Hubly Drill, which the company describes as an innovative...
Get Ahead of Stroke campaign launches Survive Stroke Week from 15–21...
The Get Ahead of Stroke campaign is launching Survive Stroke Week from 15–21 May—an observance aimed at increasing awareness of stroke symptoms and the...
World-renowned clot science drives outstanding EMBOTRAP stent retriever outcomes in MASTRO...
This advertorial is sponsored by CERENOVUS.
The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design...
Cerevasc to present data on minimally invasive CNS delivery system at...
Cerevasc has announced that data on its minimally invasive central nervous system (CNS) delivery system will be presented for the first time at the...
Computing the future: Exploring ChatGPT’s potential role in neurosurgical practice
Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not...
Systematic review queries how far PPTA aneurysm management is along “the...
A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery...
ConcertAI’s TeraRecon announces release of AI-driven Neuro Suite
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage,...
MIVI completes enrolment for study of Q revascularisation system in acute...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...
Medical therapy improvements mean “the time has come” to reconduct prior...
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward...
Clinical stroke research in Canada receives million-dollar grant boost
The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this...
NeuroNews’ top 10 most popular stories of April 2023
A number of potentially contentious issues caught the eye of our readers in April—including how best to define 'success' in stroke thrombectomy; efforts to...
NeuroOne announces US commercial launch of Evo sEEG electrodes
NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA.
Zimmer Biomet holds exclusive worldwide distribution rights...
Feinstein Institutes awarded US$3.4 million to study rTMS therapy in schizophrenia
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening...
Stryker completes acquisition of Cerus Endovascular
Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices...
Study finds worse post-stroke neurologic outcomes in Spanish-speaking Americans
New research has indicated that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans.
A recent study, which looked at whether the...
Cerenovus announces commercial availability of Cerepak detachable coils in USA
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been...
Early diagnosis and treatment needed in “often underreported” post-stroke cognitive impairment
More than half of all stroke survivors may develop cognitive impairment within a year after their stroke, and one in three are at risk for developing dementia...
ESOC to return with fully on-site format and diverse stroke programme
Having taken place via a virtual format in 2021, and as a hybrid meeting last year, the 2023 European Stroke Organisation Conference (ESOC; 24–26...
SynerFuse announces presentation of IDE proof-of-concept study data
SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s...
Vascular community split over “death” of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on...
Penumbra launches new RED 43 reperfusion catheter for mechanical thrombectomy
Penumbra recently announced the launch of the latest addition to its RED family of catheter devices for mechanical thrombectomy, the RED 43 reperfusion catheter.
According...
NICO announces initial positive results from ENRICH trial
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting...
Route 92 gains US FDA clearance for complete stroke treatment system
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system,...
Biotronik announces US FDA approval of Prospera spinal cord stimulation system
Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the...
Cercare and ConcertAI partner to improve neurovascular clinical workflows
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of...
ENRICH trial data on minimally invasive ICH surgery to be presented...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...
RapidAI receives US FDA 510(k) clearance for new imaging product to...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is...
New WIST guidelines seek to improve access and standardise training in...
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in...
Nerivio demonstrates real-world effectiveness as migraine treatment in adolescents
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology....
Michael J Fox Foundation announces “significant breakthrough” in search for Parkinson’s...
A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF)...
The new standard for SCS therapy—neural activation measurement, targeting and maintenance
Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In...
Initial cases indicate lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Adept launches Adducted Arm Scoop product for use during image-guided procedures
Adept Medical has launched the Adducted Arm Scoop—an improved solution for supporting the adducted arms of supine patients during image-guided procedures.
Adept’s new, “extremely durable”...
Saluda, Neuromod, Neuvotion secure funding rounds to boost neuromodulation technologies
This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of...
Evidence indicates effectiveness of brain stimulation in upper-limb stroke rehabilitation
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and...
Annalise.ai gains seven new 510(k) clearances for brain and chest imaging...
Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence...
DAPT at discharge reduces stroke and mortality risk versus other drug...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT),...
Reach Neuro receives Breakthrough Device designation for restorative stimulation device in...
Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small...
Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...
New study shows benefits of BioWave’s peripheral nerve stimulation in chronic...
The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral...
First-pass effect or rule of three? Definition of procedural success remains...
While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical...
Intraoperative adverse events found to impede favourable outcomes in microsurgical aneurysm...
A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated with microsurgery experienced favourable...
New spectroscopy probe could enhance deep brain stimulation procedures for Parkinson’s
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors...
Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...
Astrocyte to initiate extended infusion Phase 1b study of cerebroprotective drug
Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers....
CHI Memorial announces participation in “milestone” stroke study with novel ultrasound...
The Catholic Health Initiatives (CHI) Memorial Stroke and Neuroscience Center has announced its participation in the national research study, BUBL, stating that it was...
Stent-assisted coiling fails to show superiority versus coiling alone in unruptured...
A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured...
NeuroNews’ top 10 most popular stories of March 2023
In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s...
Review concludes SCS benefits do not outweigh associated risks and costs...
A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated...
NeuroNews issue 49 – US
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...
NeuroNews issue 49 – EU
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...
Trial underway involving neurointerventionist “retaliated against” for refusing concurrent on-call shifts
The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his...
Chest, Heart and Stroke Scotland applauds decision to reinstate “vital” thrombectomy...
The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Q’Apel Medical granted CE-mark approval for Walrus balloon guide catheter
Q'Apel Medical has been granted a CE mark under the European Medical Device Regulation (MDR) for Walrus, its balloon guide catheter (BGC) product used...
Vitor Mendes Pereira
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something...
Cerevasc appoints Adel Malek as its new chief medical officer
Cerevasc has named neurosurgeon Adel Malek as its new chief medical officer. This appointment will allow the company to further accelerate the development and clinical...
Brain Aneurysm Foundation welcomes Carolina Maier to its board of directors
The Brain Aneurysm Foundation (BAF), a leading global research and advocacy organisation committed to improving treatment and care for brain aneurysms, has announced the addition...
Lessons learned from establishing a 24/7 stroke thrombectomy service
Alongside his colleagues at the Barts Health NHS Trust, Levansri Makalanda (London, UK) was responsible for setting up the second ever 24/7 mechanical thrombectomy...
Recent addition to European flow diverter market performs well in multicentre...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...
Athersys announces changes to MASTERS-2 trial endpoints following US FDA meeting
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the US Food and Drug Administration (FDA)....
Brainomix receives US FDA clearance for flagship stroke AI imaging software
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to...
COMMAND trial set to begin enrolment at third US site
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health...
Female physicians in neurointerventional surgery: Breaking down barriers
In the latter stages of 2022, the Society of NeuroInterventional Surgery (SNIS) released a position statement advocating pregnancy and parental leave policies in neurointerventional...
UK MHRA awarded £10 million to fast-track patient access to medical...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of...
ObvioHealth to conduct decentralised trial with Mi-Helper device for treatment of...
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the treatment of migraines. The...
NeuroOne completes initial animal implant of thin-film paddle lead for spinal...
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS)....
MindRhythm announces publication of EPISODE-PS trial data on ischaemic stroke detection...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), has announced the first publication of results from its EPISODE-PS trial in...
Dystonia patient undergoes successful brain pacemaker surgery while watching cartoons
A dystonia patient in Turkey who had been having uncontrollable involuntary contractions in her legs and arms for the past five years recently underwent...
Scientia receives US FDA clearance for Aristotle Colossus macrowire
Scientia Vascular has announced the US Food and Drug Administration (FDA) 510(k) clearance of the Aristotle Colossus macrowire. The company claims that this device...
Carthera and US FDA align on key aspects of potential pivotal...
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of brain diseases—has announced today the completion of an end-of-Phase...
European Society for Brain Stimulation “strongly opposes” reclassification of non-invasive devices
The European Society for Brain Stimulation (ESBS) has said it “strongly opposes” the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation (NIBS)...
Get Ahead of Stroke campaign debuts new online resources for EMS...
With Brain Awareness Week (13–19 March) approaching, the Get Ahead of Stroke campaign has announced it is debuting new online resources for emergency medical...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Study finds “dismally low” global access to thrombectomy and “enormous disparity”...
The Society of Vascular and Interventional Neurology (SVIN) has released its first global analysis of access to mechanical thrombectomy for the treatment of large...
Neuromod gains US FDA approval for bimodal neuromodulation tinnitus treatment
Neuromod Devices has announced that the US Food and Drug Administration (FDA) has granted de novo approval to Lenire—the first bimodal neuromodulation device of its kind...
Nevro announces full US market launch of HFX iQ spinal cord...
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following...
Five-year project sets out to improve brain aneurysm treatments with customisable...
A team from the University of Oklahoma (Norman, USA) has embarked on a five-year research project with the intention of designing a device that...
Minneapolis hospital opens “nation’s first” paediatric hybrid intraoperative MRI neurosurgery suite
Children's Minnesota (Minneapolis, USA) has claimed, in a press release, to have become the first health system in North America to open a paediatric hybrid intraoperative magnetic resonance...
Mainstay announces publication detailing economic impact of restorative neurostimulation
Mainstay Medical has announced the publication of a paper, titled “Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact",...
Spinal cord stimulation found to “instantly improve” post-stroke arm and hand...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to...
US physicians publish “first reported use” of Indigo aspiration system for...
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus...
Increasing coiling porosity demonstrates greater impact in male cerebral aneurysm patients
Altering the porosity of coiling in the treatment of cerebral aneurysms has been found to have a greater impact on maximum oscillatory shear index...
NeuroNews’ top 10 most popular stories of February 2023
Stroke research was the flavour of the month throughout February on NeuroNews, with highlights from the International Stroke Conference (ISC; 8–10 February, Dallas, USA)...
Drug-free migraine treatment gains additional US FDA clearance for preventative use
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive...
NovaSignal announces donation of NovaGuide 2 intelligent ultrasound system to Jacobs...
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke...
Feinstein Institutes reports on early vagus nerve mapping and details novel...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve...
Route 92 announces 80th patent for Monopoint operating platform
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is...
High-frequency spinal cord stimulation may be associated with “significant decrease” in...
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs,...
Methinks receives CE-mark certification for AI-based stroke triage software
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of...
Hotter weather during transportation associated with improved thrombectomy outcomes
A study intended to examine the impact of different weather conditions and modes of transport on mechanical thrombectomies in stroke patients has found a...
Uric acid-based neuroprotective agent demonstrates promise in large animal study
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that...
Cognito announces first patient enrolment in US pivotal study of novel...
Cognito Therapeutics has announced the first patient enrolment in its US pivotal study, HOPE, which is designed to demonstrate the safety and efficacy of...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Incepto partners with Avicenna.AI to improve stroke management in Europe
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform...
Randomised trial fails to show benefit with bypass surgery in symptomatic...
The initial findings from a recent randomised controlled trial (RCT) do not support the addition of extracranial to intracranial (EC-IC) bypass surgery to the...
ANGEL-ASPECT data bolster evidence for thrombectomy in large infarct core stroke
A randomised trial has found mechanical thrombectomy procedures performed within 24 hours of symptom onset to be more effective than standard medical care in...
Brainomix technology integrated into new UK atrial fibrillation study
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
Trend toward gender parity in faculty “has not translated” to stroke...
The favourable trend toward gender parity that has been seen within neurology faculty over the past decade “has not translated” to the leadership of...
Viz.ai collaborates with Johns Hopkins to expedite patient enrolment in brain...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for...
Thrombectomy appears comparable to medical management in treating ACA occlusion stroke
Mechanical thrombectomy appears to be a safe and technically feasible treatment option for ischaemic strokes caused by primary isolated anterior cerebral artery (ACA) occlusions...
Dual antiplatelet therapy comparable to thrombolysis in minor, non-disabling ischaemic stroke
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to...
The positive clinical impact of a comprehensive, compatible stroke solutions portfolio
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices,...
Randomised trial finds active tDCS to be effective treatment in women...
A randomised, triple-blinded clinical trial involving 35 women has found that active transcranial direct current stimulation (tDCS)—delivered at an intensity of 2mA and across...
Rhaeos raises US$10.5 million in Series A funding to boost hydrocephalus...
Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more...
Athersys granted clinical Type B meeting with US FDA to discuss...
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with...
New certifications aim to standardise and improve stroke care in Mexico
Hospital institutions in Mexico will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Mexican stroke...
Perfuze announces US FDA clearance and first US clinical use of...
Perfuze has secured its first product clearance from the US Food and Drug Administration (FDA) for the company’s Millipede 088 access catheter. The first...
MindMaze launches Izar neurological rehabilitation device in USA and Europe
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked...
Celery seed derivative shows promise as neuroprotectant in acute ischaemic stroke
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological...
IRRAflow system leads to favourable clinical outcomes versus passive drainage in...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the...
Chinese TRACE II trial deems tenecteplase non-inferior to alteplase in ischaemic...
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used...
New smartphone app may help to identify stroke symptoms as they...
A new smartphone application called FAST.AI (Neuronics Medical) may help people who are having a stroke—or their family and caregivers—to recognise common stroke symptoms in real...
Wallaby/Phenox announces presentation of PROST trial data at ISC 2023
Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of the PROST (Preset for occlusive stroke treatment) randomised clinical...
EndoStream announces first patient enrolment in TORNADO-US study
EndoStream Medical has announced that the first patient has been enrolled in the TORNADO-US clinical study in the USA, which will evaluate the Nautilus intrasaccular system...
SELECT2 results support thrombectomy use in stroke patients with large infarct-core...
An international clinical study has found that patients experiencing a ‘large’ stroke—characterised by a greater infarct-core volume on imaging—had a dramatically better recovery after...
ISC 2023 sees presentation of positive data on new stroke drugs...
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke...
Blood pressure lowering after EVT “should be customised” owing to safety...
The administration of medications to lower systolic blood pressure in acute ischaemic stroke patients who have undergone a successful mechanical thrombectomy procedure—also known as...
Hyperfine announces new data on portable MRI in post-thrombectomy stroke patients
Hyperfine has announced the presentation of new stroke patient follow-up data regarding the use of the Swoop system—which it claims is the world’s first US...
Two cardiovascular medicines found to be “well-tolerated” in small vessel stroke
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for...
Wallaby/Phenox announces US FDA clearance of Preset thrombectomy device
Phenox, a Wallaby Medical company, has announced the US Food and Drug Administration (FDA) 510(k) clearance of its Preset thrombectomy device for the treatment...
Continuous monitoring detects atrial fibrillation in 20% of atherosclerotic stroke survivors
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...
Real-world study demonstrates “highly clinically important” time saving with Viz platform
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which...
Neuroprotective agent linked to reduced death and disability in ischaemic stroke...
ApTOLL, a neuroprotectant medication intended to shield the brain from tissue damage, has been linked to reduced death and disability when used alongside standard...
Avicenna.AI announces total funding of US$10 million after securing Series A...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round...
Imperative Care announces formation of digital stroke recovery company Kandu Health
Imperative Care has announced the formation of digital health startup Kandu Health as an independent company, with the aim of “changing the course of stroke...
Prior thrombolysis improves outcomes for M2 occlusion stroke patients undergoing thrombectomy
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes than thrombectomy alone in stroke patients with M2 occlusions,...
New AHA statement should be seen as “call to action” in...
A new American Heart Association (AHA) scientific statement provides guidance on staffing, leadership and resource requirements for hospital stroke centres, with the intention of...
Czech study finds thrombectomy and IVT rates “remained unchanged” during first...
A national study conducted by researchers in the Czech Republic has found that, while stroke admissions in the country declined during the first year...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
New JMIR journal to focus on “intersection between clinical neuroscience and...
JMIR Publications has announced the expansion of its journal portfolio with JMIR Neurotechnology (JNT)—an open-access, peer-reviewed journal focused on the intersection between clinical neuroscience and...
SCS therapies can play a role in cancer-related pain treatment despite...
Spinal cord stimulation (SCS) therapies targeting the dorsal column “may be considered” within the multimodal treatment plans typically required by cancer patients, but it...
LivaNova launches new vagus nerve stimulation therapy for drug-resistant epilepsy
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with...
Meta-analysis including recent basilar trials signals benefit of EVT in posterior...
A meta-analysis of recent basilar artery occlusion trials—including ATTENTION and BAOCHE—has further indicated the potential benefits held by endovascular therapy (EVT) in treating posterior-circulation...
NeuroNews’ top 10 most popular stories of January 2023
The latest and greatest in neurointerventional technologies feature among NeuroNews’ most read stories from January, including a direct intravascular imaging tool; a new, stroke-specific...
Basking Biosciences to present trial data on novel reversible thrombolytic agent...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic...
Axonics receives US FDA approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation (SNM) system—a technology intended to provide...
Sex found to be “important variable” in study and treatment of...
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Global societies lead tributes to esteemed neurologist Ralph Sacco
Esteemed neurologist Ralph Sacco passed away at the age of 65 earlier this month, and a number of prominent neurology and stroke societies have...
Boston Scientific announces three-month data from SOLIS trial at NANS
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes to conventional medical management (CMM) in chronic pain patients...
Thrombectomy use rates underscore recent advances in Latin American stroke care
A systematic review of interventional acute ischaemic stroke treatments in Latin American countries has found that mechanical thrombectomy usage in these regions is “comparable...
Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from...
Abbott gains US FDA approval for SCS therapy in painful diabetic...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful...
Transcutaneous auricular VNS proves effective in patients with mild cognitive impairment
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive...
CELLO II balloon guide catheter gains US FDA approval for peripheral...
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can...
Blackford and Brainomix announce partnership to advance AI-assisted stroke care
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...
Chinese MATCH study finds microsurgery is “dominant” brain AVM treatment
Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland China and produced early findings indicating that microsurgery is...
Hospitals without high-level designation more likely to miss strokes following TAVI...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that...
ENCHANTED2/MT data indicate intensive blood pressure lowering “should be avoided” after...
Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure...
Clinical trial to test novel wearable treatment for chronic pain and...
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will...
Novel digital intervention meets primary endpoint in chronic stroke trial
MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was...
Basecamp Vascular announces upcoming appointment of new CEO
Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023.
He succeeds interventional neuroradiologist Raphaël Blanc (Foundation Rothschild...
Challenging the status quo in stroke care
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...
AHA statement: Even transient stroke symptoms require emergency assessment
Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke,...
Squid liquid embolic agent deemed safe and effective for high-grade DAVFs
The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the...
Saluda Medical announces presentation of 36-month EVOKE trial data at NANS...
Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual...
Atrial fibrillation does not modify treatment effect of bridging thrombolysis, study...
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...
Abbott presents new data on streamlining patient-reported measures, BurstDR and more...
Abbott presented new data in more than 30 presentations and posters at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las...
Interventions—not neuroimaging—found to be driving increased ischaemic stroke costs
A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from...
Neuralace enrols first patients in AT-PDN study evaluating Axon therapy
Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study.
The multicentre AT-PDN study...
Neuroprotection “renaissance” offers hope for improved stroke therapies in future
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears...
First human cases performed with high-frequency imaging offering “unprecedented potential” in...
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company...
Systematic review deems coated stents plus SAPT feasible in ruptured aneurysms
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to...
Athersys provides update on ischaemic stroke and haemorrhagic trauma trials of...
Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided...
Medtronic to highlight sensing-enabled spinal cord stimulation research at NANS 2023
Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal cord stimulation (SCS) therapy at the North American Neuromodulation...
So, you want to be a principal investigator?
A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and...
Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...
DISTAL trial will elucidate non-dominant M2, M3 and PCA occlusions but...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December...
SynerFuse announces “milestone” solo spine surgeon procedure in DRG stimulation study
Justin Zenanko, the CEO of SynerFuse, announced today that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse...
Nalu Medical announces publication of two spinal cord stimulation clinical studies
Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve...
NeuroNews’ top 10 most popular stories of December 2022
The final weeks of 2022 saw the global burden of stroke gain a great deal of attention from NeuroNews’ online audience, including discussions around...
Mathematical model examines factors influencing risk of cerebral aneurysm rupture
Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including shape and size—that influence aneurysm rupture risks prior to...
Nevro announces two late-breaking data presentations set for NANS 2023
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been...
Increased annual stroke rate in Canada underscores need for strong treatments...
A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This...
Imperative Care announces FDA clearance and initial cases with stroke-specific radial...
Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s...
Abbott launches “world’s smallest” implantable, rechargeable SCS system for chronic pain
Abbott has announced the US Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which it claims is...
Insightec receives US FDA approval to treat essential tremor patients’ second...
Insightec recently announced it has received an additional US Food and Drug Administration (FDA) approval for treatment of essential tremor using its Exablate Neuro...
Study reveals racial disparity in brain tumour surgeries recommended to US...
A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published...
Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...
European Stroke Organisation taskforce delivers update on thrombolytic drug shortages
The thrombolysis taskforce of the European Stroke Organisation (ESO) executive committee has provided an update on current shortages of alteplase and tenecteplase, detailing outcomes...
Shelley Renowden
Through her many years as a consultant neuroradiologist at the North Bristol NHS Trust (Bristol, UK), as well as organising the European Course in...
Study indicates safety of novel transmural access to carotid artery perivascular...
A transmural approach for accessing the perivascular tissues of the cervical carotid artery has been deemed safe following initial evaluations in a swine model.
Geoffrey...
Technological advances could render 3D printing a “major manufacturing tool” for...
The utilisation of 3D printing to make drug-eluting stents may currently be in its infancy, but the advantages it carries—such as the ability to...
Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...
Sonorous uses new device to treat patients with symptomatic cerebral venous...
Sonorous NV has announced the treatment of the first patients in North America with the BossStent device, which is designed to treat patients with...
Stryker launches “state-of-the-art” neurovascular lab to accelerate stroke care innovation
Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology...
How do we improve the treatment of stroke patients in the...
This educational supplement has been sponsored by MicroVention.
Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several...
Current literature supports stenting as feasible bailout option after failed thrombectomy
Permanent intracranial stenting offers a feasible, safe ‘bailout’ option following a failed mechanical thrombectomy procedure. This was the concluding message delivered recently by Sarah...
NeuroNews issue 48 – US
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...
NeuroNews issue 48 – EU
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...
Medtronic Neurovascular partners with Avail to boost real-time connectivity
Medtronic Neurovascular has announced a new partnership with Avail Medsystems, creating the Medtronic Remote Connectivity Program (Medtronic RCP) in the process.
The goal of this...
Spinal cord stimulation and other modalities will benefit from greater understanding...
Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned...
Axonics gains Health Canada approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system as a treatment for bladder and bowel dysfunction.
The newly...
IRRAS receives new US FDA 510(k) clearance for next-generation IRRAflow control...
IRRAS has announced that it recently received regulatory clearance from the US Food and Drug Administration (FDA) to activate all of the functionality on...
Eight winners advance to Phase 2 in Neuromod Prize competition
Eight winners have been exclusively invited to join Phase 2 of the Neuromod Prize, a US$9.8 million competition to accelerate the development of targeted...
NeuroOne successfully completes feasibility study with OneRF ablation system
NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted...
NeuroNews’ top 10 most popular stories of November 2022
Key announcements from a number of the neurovascular market's leading companies generated interest from NeuroNews' online readers last month, including updates from the recent...
Timothy Deer to receive inaugural NANS Presidential Merit Award
Renowned pain management expert and clinical professor of anaesthesiology Timothy Deer (West Virginia University, Charleston, USA) is set to receive the inaugural Presidential Merit...
Study identifies “urgent need” to reduce burden of ischaemic stroke in...
A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions,...
Intraoperative neuromonitoring may drive a new era in spinal cord stimulation...
“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the...
Clinicians urge Scottish government to reverse £7 million thrombectomy funding cut
Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding...
Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Wise receives US FDA clearance for intraoperative monitoring cortical strip
Wise, a company that develops next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing applications, has announced the US Food and Drug Administration (FDA)...
LuSeed Vascular appoints Robert Stern to board of directors
LuSeed Vascular has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as the vice chairman of the company’s...
SNIS: Physicians “should not have to choose” between family life and...
The Society of NeuroInterventional Surgery (SNIS) has released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, also voicing support for...
NeuroPace initiates feasibility study of responsive neurostimulation for Lennox-Gastaut syndrome
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was...
Viz.ai partners with Cercare to support neurovascular clinical decision-making
Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...
Neurologica announces US FDA 510(k) clearance of BodyTom 64
Neurologica, a subsidiary of Samsung Electronics, has announced that its head-to-toe trauma imaging solution—the BodyTom 64 point-of-care mobile computed tomography (CT) scanner—has received 510(k) clearance...
Cerevasc co-founders honoured with Innovation Award at SVIN 2022
Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and...
Swiss parliament votes to accept US FDA-approved medical devices
The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland.
A motion...
RSNA 2022: New research improves understanding of ADHD, migraine and post-COVID...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new...
Vesalio appoints VP of US sales, announces publication of “impressive” first-pass...
Vesalio has today announced the appointment of a new vice president (VP) of US sales, Bob Bushok, who will oversee commercial strategy and execution...
Abbott to receive multiple CES 2023 awards for neurostimulation and pacemaker...
Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards...
Aidoc secures new FDA clearances for neurovascular and cardiovascular detection tools
Aidoc has announced it has increased its total number of US Food and Drug Administration (FDA) clearances to 11 with the addition of two...
Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment
Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...
Intermittent stimulation of the DRG produces comparable chronic pain results to...
Intermittent dorsal root ganglion stimulation (DRG-S) has been shown to produce comparable results to continuous stimulation across a two-week period, as reported in Neuromodulation:...
Mainstay announces publication of post-market data from ongoing chronic low back...
Mainstay Medical has announced the publication of data from a single-centre, real-world study with one-year clinical follow-up of patients selected from its ReActiv8-C study,...
Avicenna.AI partners with CARPL.ai to provide AI-powered radiology solutions
Avicenna.AI has today announced a distribution agreement with CARPL.ai—a company providing a technology platform that enables service-provider-oriented testing, validation and deployment of artificial intelligence...
NoNO announces first patient dosed with NoNO-42 in Phase 1 study
NoNO Inc has announced the dosing of the first participant in its Phase 1 clinical trial evaluating NoNO-42—a next-generation neuroprotective drug developed in the...
Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...
The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...
Why responsive neurostimulation is garnering “wide interest” from the epilepsy field
To date, thalamic responsive neurostimulation (RNS) has shown real potential in the treatment of patients with drug-resistant epilepsy. Mark Richardson (Massachusetts General Hospital, Boston,...
Cerenovus reveals positive stent-retriever thrombectomy outcomes within EXCELLENT registry
Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...
SPR Therapeutics debuts occipital nerve stimulation data at ASRA 2022
At the 21st annual American Society of Regional Anesthesia (ASRA) pain medicine meeting (17–19 November 2022, Orlando, USA), SPR Therapeutics is highlighting five new data sets demonstrating...
Route 92 Medical announces expansion to new manufacturing site in Utah
Route 92 Medical has announced its expansion to a new high-volume manufacturing site in Salt Lake City, USA. This 40,000-square-foot site will allow Route...
IRRAS announces commercial US partnership with Medtronic for IRRAflow system
IRRAS recently announced it has signed a sales agency agreement to promote its IRRAflow system in the USA with Medtronic.
During the initial pilot phase of this...
World Stroke Congress bolsters evidence on optimal thrombectomy and thrombolysis approaches
While much-needed improvements to existing triage and transport protocols for acute stroke patients were a leading topic of focus on World Stroke Day (29...
Collavidence: A global project looking to break down longstanding barriers in...
As per its own mission statement, Collavidence wants to “make medical research collaboration and funding easier, more accessible and more transparent”, paying mind to...
Contego completes enrolment of PERFORMANCE II carotid stent trial
Contego Medical has announced that enrolment of the PERFORMANCE II clinical trial has been completed.
PERFORMANCE II is intended to evaluate the safety and effectiveness...
CVRx launches new version of neuromodulation device intended to treat heart...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...
Brainomix and Visionable announce partnership to optimise UK stroke care pathway
Brainomix is set to strategically partner with Visionable, a real-time clinical collaboration platform designed to enable virtual healthcare models, in an attempt to transform...
New study finds 85% of aneurysms identified by Viz ANEURYSM had...
Viz.ai has shared highlights from new data set to be presented at next week’s Society of Vascular and Interventional Neuroradiology (SVIN) annual meeting (16–19...
Optically generated focused ultrasound shows promise for non-invasive brain stimulation
In a new paper published in Light: Science and Applications, a team of scientists and engineers led by Ji-Xin Cheng and Chen Yang (Boston...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
Positive animal-model results with ABILITY BCI are “important step” towards human...
The Wyss Center for Bio and Neuroengineering in Geneva, Switzerland has today revealed the latest preclinical neural data acquired with its fully implantable ABILITY...
Insightec announces sustained and significant tremor improvement with focused ultrasound thalamotomy
Insightec has announced the publication of what it claims is the largest prospective, long-term follow-up study to date of unilateral magnetic resonance imaging-guided focused...
NeuroNews’ top 10 most popular stories of October 2022
A common theme surrounding last month's World Stroke Day (29 October) was the fact that, while acute ischaemic stroke therapies may have advanced markedly...
New CMS telehealth designation extends coverage of Abbott’s NeuroSphere virtual clinic
As part of its Medicare Telehealth Services List, the US Centers for Medicare and Medicaid Services (CMS) will continue to cover the use of...
iVascular launches new neurovascular portfolio with four CE-marked devices
Vascular device company iVascular has announced the expansion of its therapeutic areas with the launch of a new neurovascular pipeline, having gained CE-mark approval...
BAOCHE trial results supporting thrombectomy for basilar artery stroke published in...
Results from the BAOCHE randomised controlled trial (RCT), which found that the addition of thrombectomy to standard medical care within 6–24 hours in basilar...
Medtronic study finds post-stroke protocols “vary significantly” between community hospitals and...
Medtronic has announced the first results from its DiVERT clinical study, which showed that post-stroke workflow protocols and cardiac monitoring vary significantly across community...
World Stroke Day: WSO to launch new Stroke Certification initiative
On World Stroke Day (29 October 2022), the World Stroke Organization (WSO) has announced the launch of a new programme that aims to drive...
BE FAST: Physicians advocate greater public awareness on World Stroke Day
On World Stroke Day 2022 (29 October), US physicians from the Get Ahead of Stroke campaign are urging the public to embrace the “simple...
Synchron to begin COMMAND trial enrolment at University of Pittsburgh
Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA.
The COMMAND trial is an early...
Medtronic announces launch of neurovascular Co-Lab platform
Medtronic has announced the launch of its neurovascular Co-Lab platform, which is designed to accelerate "urgently needed" innovation in stroke care and treatment.
The company...
NICO raises US$12.5 million in oversubscribed investment round
NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...
NeuroOne receives US FDA 510(k) clearance to market Evo sEEG system...
NeuroOne Medical Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology...
Bruce Ovbiagele named editor-in-chief of the Journal of the American Heart...
Bruce Ovbiagele, associate dean and professor of neurology at the University of California San Francisco (UCSF; San Francisco, USA) and chief of staff at...
Philips to highlight latest advances in stroke care at 2022 World...
Royal Philips today announced it will showcase the company’s latest advances to support the treatment of stroke patients at the 14th annual World Stroke...
Vessel-wall imaging could hold the key in “known yet understudied” phenomenon...
Following the publication of a case report in Topics in Magnetic Resonance Imaging, researchers from Malaysia have indicated that the use of vessel-wall imaging...
Axoft launches ‘soft’ brain-implant technology, gains US FDA Breakthrough Device designation
Neurotechnology start-up Axoft has launched and announced US Food and Drug Administration (FDA) Breakthrough Device designation for its brain-machine interface (BMI) technology intended to...
Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments
Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...
Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial
Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...
RAPID Aneurysm programme shows positive early performance in retrospective study
RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
Vesalio announces EU MDR certification of neurovascular product lines
Vesalio has announced EU Medical Device Regulation (MDR) certification of its product lines—achieving this “significantly ahead” of its May 2023 deadline, according to a...
Systematic review finds “strong evidence base” supporting deep brain stimulation for...
Deep brain stimulation (DBS) can halve the symptoms of severe obsessive-compulsive disorder (OCD), according to the findings of a pooled data analysis of available...
New white paper details early experience with ABILITY brain-computer interface
A new white paper, released by the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), reveals the first neural signals recorded by the ABILITY...
Nevro announces US FDA approval of HFX iQ system to personalise...
Nevro Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS)...
Society of Vascular and Interventional Neurology announces 40-second stroke awareness challenge
The Society of Vascular and Interventional Neurology (SVIN) has said it wants to create awareness around stroke events leading up to World Stroke Day...
NeuroPace announces first patient implant in NAUTILUS pivotal study
NeuroPace has announced the first patient has been implanted in the NAUTILUS clinical trial, a pivotal study that will evaluate the safety and effectiveness...
Neuspera announces first successful Nuvella system implant in second phase of...
Neuspera Medical has announced the first patient has been successfully implanted with the Nuvella system in its pivotal SANS-UUI clinical trial, which will evaluate...
IRRAS announces educational webinar series alongside Jacobs Institute and University of...
IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...
Researchers develop injectable biomaterial with potential in endovascular aneurysm treatment
Researchers in the USA have developed an injectable, ‘toothpaste-like’ biomaterial that may offer promise in the treatment of intracranial aneurysms as an alternative to...
Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses...
Process times and regional variation are main areas of concern for...
Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...
NICO announces completed enrolment in trial evaluating new ICH intervention approach
NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...
Physicians should prioritise first-pass optimisation over speed in thrombectomy procedures
Achieving clot retrieval with the fewest possible number of passes is critical in mechanical thrombectomy, and may even hold greater importance than how quickly...
Nevro announces first global manufacturing operation with Costa Rica expansion
Nevro Corporation announced recently that the US Food and Drug Administration (FDA) has approved its manufacturing operations in Costa Rica for the production of its proprietary...
US study bolsters recent evidence supporting tenecteplase in ischaemic stroke care
Tenecteplase, a newer-generation intravenous thrombolysis (IVT) drug, has outperformed the traditional treatment (alteplase) for ischaemic strokes in several key areas, demonstrating better health outcomes...
NeuroNews’ top 10 most popular stories of September 2022
The latest and greatest in neurointerventional clinical research buzzed our readers in September, with new studies on dual antiplatelet therapy (DAPT) duration, radial versus...
Microvention celebrates 25 years in neuroendovascular technologies with ‘Patient’s Day’
Microvention, a wholly owned subsidiary of Terumo Corporation, today celebrated its 25-year anniversary in the neuroendovascular technologies industry.
The capstone of Microvention’s 25th anniversary celebration...
Wallaby/phenox officially announces global launch of Pegasus HPC stent system
Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...
HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial
In the randomised HD-RECOVERY clinical trial, the use of high-definition transcranial direct current stimulation (HD-tDCS) has been found to be associated with a statistically...
Magnus receives US FDA clearance for SAINT neuromodulation system in severe...
Magnus Medical has announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its SAINT neuromodulation system for the treatment of...
Flow diverting, stenting and beyond—HPC technology offers “limitless” potential in neurointervention
This advertorial is sponsored by phenox.
Following the publication of a study assessing the use of Hydrophilic Polymer Coating (HPC) technology with the p64 MW...
UK NICE publishes interventional procedure guidance for ReActiv8 restorative neurostimulation
Mainstay Medical has announced that the National Institute for Health and Care Excellence (NICE), a public body of the UK Department of Health, has...
SWIFT-DIRECT sub-analysis finds effect of bridging thrombolysis is preserved over time
A recent sub-analysis of the SWIFT-DIRECT trial, which is published in the Journal of NeuroInterventional Surgery (JNIS), has found “no evidence” that the effect...
Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine
Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...
Vesalio announces US FDA approval of NeVa VS to treat cerebral...
Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...
Similar complication rates observed following DAPT discontinuation within and past 90...
The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...
Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system
Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...
Sheba and Thomas Jefferson to build “state-of-the-art” neuroscience centre in Israel
Sheba Medical Center, which is located in Ramat Gan, Israel and claims to be the country’s largest medical centre, has announced a major collaboration...
The inevitable growth of neurovascular robotics: Improved precision today, potential remote...
This advertorial, sponsored by Siemens Healthineers, is intended for readers outside of the USA.
The majority of cases the CorPath GRX Neurovascular Robotic System (Siemens...
Adjunctive therapy demonstrates comparable aneurysm occlusion rates to established flow diverters
The Neqstent coil-assisted flow diverter (Cerus Endovascular) has demonstrated comparable occlusion rates to those seen with other, similar flow diversion technologies, as well as...
Onward reports positive study results in restoring arm and hand function...
Onward Medical recently announced that the Up-LIFT pivotal study evaluating its non-invasive spinal cord stimulation (SCS) ARC-EX therapy achieved its primary effectiveness endpoint of...
CorPath GRX robot demonstrates safety and effectiveness in neurovascular aneurysm treatment
Corindus, a Siemens Healthineers company, announced today the recent presentation of results from a “first-of-its-kind” study demonstrating the safety and effectiveness of robotic-assisted neurovascular...
Increased coiling rate suggests shift towards endovascular techniques during COVID-19 pandemic
A global study published in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP) has revealed that, while ruptured aneurysm clipping rates remained largely unchanged,...
How AI, automation, robotics and other innovations in ultrasound are improving...
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
Axonics announces first patient implants in Canada with recharge-free sacral neuromodulation...
Axonics has announced the first patient implants in Canada with Axonics F15, the company’s newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system.
The University...
Basecamp Vascular announces first-in-human cases with steerable mechatronic guidewire
Basecamp Vascular (BCV) has announced a “major step” in the development and evaluation of steerable mechatronic guidewires for stroke treatment via its GECKO system....
Self-administered tDCS reduces knee osteoarthritis pain in older adult patients
Home-based, self-administered transcranial direct current stimulation (tDCS) has demonstrated feasibility, acceptability and significant reductions in clinical pain intensity in older adults with knee osteoarthritis,...
Penumbra announces European launch of RED reperfusion catheters for stroke care
Penumbra announced today that its RED reperfusion catheters have secured a CE mark and are now commercially available in Europe. The catheters are part of...
Isil Saatci
Isil Saatci has been practising interventional neuroradiology (INR) in Ankara, Turkey for almost the entirety of her career—initially at Hacettepe University, where she also...
Nevro announces positive coverage updates for treatment of painful diabetic neuropathy...
Nevro Corporation has announced that US health plan Aetna has updated its spinal cord stimulation (SCS) coverage policy to explicitly cover painful diabetic neuropathy...
Insightec announces financing up to US$200 million to support continued growth
Insightec has announced that it has signed a credit facility for up to US$200 million with affiliates of existing shareholders, Perceptive Advisors and Community Fund....
NeuroNews’ top 10 most popular stories of August 2022
In August, NeuroNews’ most read stories included new clinical data on a number of neurovascular technologies, physician viewpoints on a “historic” neurointerventional procedure in...
Neurofenix completes US$7 million Series A funding for digital stroke and...
Neurofenix has raised US$7 million in Series A funding via a round led by AlbionVC, with additional participation from HTH, InHealth Ventures, and existing...
Brainomix awarded tender to roll out AI imaging software across all...
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
Vesalio gains CE-mark approval for new “one-of-a-kind” NeVa NET thrombectomy device
Vesalio has today announced receipt of CE-mark approval for commercialisation of its new NeVa NET, which the company claims is the “first and only”...
Gimer Medical granted IDE approval for spinal cord stimulation system
Gimer Medical today announced that the company’s spinal cord stimulation (SCS) system was granted conditional investigational device exemption (IDE) approval by US Food and...
NeuroNews issue 47 – US
Highlights:
Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...
NeuroNews issue 47 – EU
Highlights:
Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...
New-look ESMINT congress to reflect on ISAT study and prioritise international...
After a long period of uncertainty triggered by a worldwide pandemic, the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September,...
Abnormal DW-MRI foci “significantly more frequent” with radial versus femoral access
A prospective analysis of 200 consecutive diagnostic cerebral angiograms has indicated that the number of diffusion-weighted magnetic resonance imaging (DW-MRI) restriction foci was “significantly...
Theranica secures US$45 million through Series C funding round
Theranica has announced the closing of its Series C funding round, with a first closing of US$45 million. New Rhein Healthcare Investors led the...
CereVasc announces first treatment in US trial evaluating eShunt for normal-pressure...
CereVasc today announced completion of the first eShunt procedure in the USA as part of a pilot study involving normal-pressure hydrocephalus (NPH) patients.
The study is being conducted...
MicroPort Neurotech receives Japanese marketing approval for Numen coil embolisation system
MicroPort Neurotech today announced that it has received marketing approval issued by the Ministry of Health, Labour and Welfare of Japan for its independently...
AiM unveils prototype of MRI-compatible neurosurgical robot, receives Sontag Foundation funding
AiM Medical Robotics has announced the unveiling of a magnetic resonance imaging (MRI)-compatible prototype of its “industry-first” robotics platform, a company press release states,...
First US Stentrode implant heralds new field in neurointerventional surgery
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...
New data demonstrate effectiveness of Penumbra system and RED catheters for...
Penumbra today announced initial INSIGHT registry data showing that its RED reperfusion catheters were successful in removing all clot types—and, additionally, results of sub-analyses...
Imperative Care announces positive, single-centre data on distal occlusion stroke treatment
Imperative Care recently announced that new data evaluating the utility of its Zoom stroke solution were presented at the 16th congress of the World...
IRRAS announces first patient treatments in DIVE study at Mount Sinai...
IRRAS has announced the initial patient treatments with the company's IRRAflow system within Mount Sinai Health System (New York, USA).
Thus far, two patients suffering...
Abbott gains US FDA approval for Proclaim Plus spinal cord stimulation...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360...
Ybrain receives Translational Research Award for tDCS technology
Ybrain recently received the Translational Research Award at this year's Neuroergonomics and NYC Neuromodulation Conferences (28 July–1 August, New York City, USA) for its transcranial direct...
J Mocco becomes 27th Society of NeuroInterventional Surgery president
J Mocco, an endovascular neurosurgeon at Mount Sinai in New York City, USA has been named the 2022 president of the Society of NeuroInterventional...
Progress update on Women in Neuromodulation: Achievements and obstacles
In light of recent progress made in alleviating gender disparities within the neuromodulation field, Magdalena Anitescu (Chicago, USA), Anne Fennimore (Boca Raton, USA), Kiran...
Minnetronix makes “world’s first” expandable brain port available to neurosurgical markets
Minnetronix Medical’s first product, which the company says was conceptualised, developed, US Food and Drug Administration (FDA)-cleared and manufactured internally, is now fully commercialised...
Randomised data support use of tDCS in Parkinson’s patients with Pisa...
Data from a randomised controlled trial (RCT), which have been published in Frontiers in Neurology, support the use of neuromodulation with transcranial direct current...
Vena Medical announces first global thrombectomy procedures with Balloon Distal Access...
Vena Medical has announced the successful treatment of the first five patients in the world using its Vena Balloon Distal Access Catheter (BDAC) at...
SNIS 2022: WEB flow diverter shown to be safe and effective...
The Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) saw research involving the Woven EndoBridge (WEB; Microvention/Terumo) device disclosed for the...
RAAS inhibitors shown to reduce risk of intracranial aneurysm rupture in...
A multicentre study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of renin-angiotensin-aldosterone system (RAAS) inhibitors—a...
SyncThink secures CE mark for EYE-SYNC digital health platform
SyncThink announced today that it has gained CE-mark certification for its EYE-SYNC technology, affirming conformity to the European Medical Device Regulation (MDR). EYE-SYNC will...
NeuroOne submits special 510(k) to US FDA for Evo sEEG electrode
NeuroOne Medical Technologies has announced the submission of a special 510(k) to the US Food and Drug Administration (FDA) for its stereoelectroencephalography (sEEG) electrode...
CereVasc announces US FDA approval for second IDE study of eShunt...
CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...
Taiwan’s FDA approves first autonomous neurosurgical navigation robot from Brain Navi
NaoTrac, a CE-certified neurosurgical navigation robot from Brain Navi Biotechnology, has achieved approval from Taiwan's Food and Drug Administration (TFDA), and submission to the...
Phase one winners announced in US$9.8 million Neuromod Prize competition
The National Institutes of Health (NIH) Common Fund has named eight winners of the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate...
NeuroNews’ top 10 most popular stories of July 2022
Updates from two major neurointervention events, the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) and LINNC Paris (30 May–1...
Silk Vista Baby demonstrates safety and effectiveness in PICA aneurysm treatment
Following a retrospective review of databases from multiple different centres, researchers have reported the safe and effective use of the Silk Vista Baby (Balt)...
Abbott introduces Canada’s first remote neuromodulation patient-care technology
Abbott recently announced the Health Canada licensing of NeuroSphere virtual clinic, a remote programming technology that the company claims is the first of its kind...
SNIS 2022: Late-breaking data bolster evidence supporting thrombectomy for BAO stroke
Late-breaking research presented at the recent Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) has shown that thrombectomy procedures can...
Stroke Association calls for 24/7 thrombectomy service across the UK
A new report released by the UK Stroke Association warns that, if thrombectomy rates remain at 2020/21 levels, a total of 47,112 stroke patients...
SNIS 2022: COVID-19 may increase stroke risk in younger patients and...
Stroke patients with COVID-19 are facing worse outcomes, and are often younger and healthier, according to research presented recently at the Society of NeuroInterventional...
SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...
SNIS 2022: Direct triage to Level 1 stroke centres reduces time...
Implementing severity-based field triage leads to faster treatment and less disability for stroke patients, according to late-breaking research presented recently at the Society of...
SNIS 2022: Neuroendovascular robotics could improve safety of complex procedures
Stroke surgery and other neuroendovascular procedures could be made safer and easier through robotics, according to research presented at the Society of NeuroInterventional Surgery’s...
Imperative Care announces positive real-world data associated with Zoom stroke solution...
Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society...
Mitchell Elkind to join AHA leadership team as chief clinical science...
The American Heart Association (AHA) has announced that Mitchell Elkind (Columbia University, New York City, USA), long-time volunteer of the organisation and renowned neurologist,...
Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...
Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
Rapid Medical gains US FDA clearance for “smallest and only” adjustable...
Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...
Route 92’s Monopoint operating platform shows 82% first-pass effect in independent...
Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...
RapidAI receives US FDA clearance for Rapid Hyperdensity
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...
“Spectacular” unilateral proptosis treatment receives LINNC Paris Best Case Award
An “interesting case” of unilateral proptosis in a 14-year-old girl, treated using a hybrid approach via direct external carotid artery (ECA) puncture, was presented...
New study to assess intracranial haemorrhage detection with flat-detector versus multi-slice...
The SPINNERS study, which has just been announced by Siemens Healthineers, will evaluate the diagnostic accuracy of non-contrast flat-detector computed tomography (CT) compared to...
Robotics, AI and other innovations in stroke and aneurysm care on...
Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...
Cerenovus announces clinical data and product showcases ahead of SNIS 2022
Cerenovus, part of Johnson & Johnson MedTech, will showcase its latest innovations in stroke care at the 2022 Society of NeuroInterventional Surgery (SNIS) annual...
Synchron announces first human brain-computer interface implant in the USA
Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure represents a significant technological milestone for scalable BCI devices...
Saluda Medical presents data on 24-month holistic response to spinal cord...
Saluda Medical has announced that Steven Falowski (Argires-Marotti Neurosurgical Associates of Lancaster, Lancaster, USA) recently presented late-breaking 24-month data from the company’s EVOKE study at...
Imperative Care announces poster presentations on Zoom stroke solution at SNIS...
Imperative Care has announced that new data from studies evaluating the utility of the Zoom stroke solution for the treatment of ischaemic stroke will...
NeuroNews’ top 10 most popular stories of June 2022
In-depth discussions regarding a “landmark” study in medium vessel occlusion (MeVO) stroke, and the first thrombectomy procedures with a novel balloon guide catheter device,...
Rare disease variant specific to East Asian patients increases post-EVT reocclusion...
Among people who received endovascular mechanical thrombectomy to remove a large vessel occlusion (LVO), those with a rare genetic disease variant found primarily in people...
Large-scale prospective studies required to elucidate antithrombotic medication outcomes
The world of interventional neuroradiology will likely need to follow the cardiology field and conduct large-scale prospective studies in order to move away from...
Abbott receives Breakthrough Device designation to explore DBS in managing severe...
Abbott recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to investigate the use of its deep brain...
NICO announces new distributor for neurosurgery markets in Australia and New...
NICO Corporation recently announced that it has partnered with Imedcare, an Australia-based supplier and distributor of devices, as its distributor for the neurosurgery markets in the medical...
NeuroOne announces first clinical case using Evo sEEG electrode technology
NeuroOne Medical Technologies today announced that the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode was recently performed by Robert Gross at Emory University in...
High-frequency SCS demonstrates “substantial improvement” in health-related quality of life outcomes
Nevro Corporation has announced that the complete 12-month results from the SENZA-PDN randomised controlled trial (RCT), including health-related quality of life outcomes in patients with...
Neuromod publishes new data showing improvement of tinnitus symptoms with bimodal...
Neuromod Devices has published the results of the company's TENT-A2 (Treatment evaluation of neuromodulation for tinnitus—stage A2) clinical trial in Scientific Reports via a...
NeuroVasc announces first patient treated in clinical trial evaluating novel stent...
NeuroVasc Technologies recently announced that the first patient has been treated in its US investigational device exemption (IDE) clinical study, the ENVI randomised controlled...
Sham-controlled studies indicate effectiveness of TMS for negative schizophrenia symptoms
A systematic review and meta-analysis published in Nature Schizophrenia has concluded that data from sham-controlled studies to date indicate the effectiveness of transcranial magnetic...
Current literature suggests promise held by electrical stimulation therapies for cerebral...
Electrical stimulation technologies, and in particular spinal cord stimulation (SCS) and sphenopalatine ganglion stimulation, offer a promising adjunct to existing therapies for cerebral vasospasm...
AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments
The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...
Tenecteplase shown to be effective for acute ischaemic stroke in large...
In what is claimed to be the largest stroke clinical trial ever run in Canada, researchers have shown that tenecteplase—a safe, well-tolerated drug commonly...
Alarming trends and alarmist myths: What is the link between COVID-19...
Over the course of the past two years, the accepted understanding of how COVID-19 spreads and functions has improved vastly, with preventative vaccines and...
COVID-19 “did not affect stroke care quality or outcomes” in largest...
In one of the first studies to investigate the overall quality of care and outcomes of stroke care for non-COVID-19 hospitalised patients during the...
Neuspera Medical announces second phase of SANS-UUI clinical trial with Nuvella...
Neuspera Medical recently announced it will begin enrolment in its pivotal clinical trial, SANS-UUI—a single-arm investigational device exemption (IDE) study that will enrol 145 patients...
Valencia Technologies announces first commercial implantation of eCoin tibial neurostimulator
Valencia Technologies Corporation has announced in a press release that it has completed the “world's first” commercial implantation of its eCoin leadless tibial neurostimulator,...
Stimwave announces sale of business and secures US$40 million in financing
Stimwave Technologies Incorporated (Stimwave) recently announced that it has reached an agreement to sell substantially all of its assets to Kennedy Lewis Management LP...
MicroTransponder raises US$53 million and appoints new CEO
MicroTransponder has closed an oversubscribed US$53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and...
Neuromodulation offers hope for patients with long-COVID
With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New...
Carthera receives FDA Breakthrough Device designation for Sonocloud-9 system
Carthera announced today that its Sonocloud-9 system has been listed as a Breakthrough Device by the Center for Devices and Radiological Health (CDRH) at...
